Advanced search

Vol 80, Supp. III (2022): Zeszyty Edukacyjne 3/2022
Wytyczne ESC
Published online: 2022-12-22

open access

View PDF (Polish) Download PDF file
Page views 580
Article views/downloads 3528
Get Citation

Connect on Social Media

Connect on Social Media

Wytyczne ESC 2022 dotyczące oceny ryzyka sercowo-naczyniowego i postępowania u pacjentów poddawanych operacjom niekardiochirurgicznym

Sigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, Trygve S. Hall, Magdy Abdelhamid, Emanuele Barbato, Stefan De Hert, Ingrid de Laval, Tobias Geisler, Lynne Hinterbuchner, Borja Ibanez, Radosław Lenarczyk, Ulrich R. Mansmann, Paul McGreavy, Christian Mueller, Claudio Muneretto, Alexander Niessner, Tatjana S. Potpara, Arsen Ristić, L. Elif Sade, Henrik Schirmer, Stefanie Schüpke, Henrik Sillesen, Helge Skulstad, Lucia Torracca, Oktay Tutarel, Peter Van Der Meer, Wojtek Wojakowski, Kai Zacharowski
DOI: 10.33963/v.kp.92024

Abstract

Not available

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008; 372(9633): 139–144.
    CrossRefPubMed
  2. Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015; 385(Suppl. 2): S11.
    CrossRefPubMed
  3. Eurostat. EU population in 2020: almost 448 million. https://ec.europa.eu/eurostat/documents/2995521/11081093/3-10072020-AP-EN.pdf/d2f799bf-4412-05cc-a357-7b49b93615f1 (March 31, 2022).
  4. Smilowitz NR, Gupta N, Guo Yu, et al. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart. 2018; 104(14): 1180–1186.
    CrossRefPubMed
  5. Lee OH, Hong SJ, Ahn CM, et al. The incidence of non-cardiac surgery in patients treated with drug-eluting stents according to age. J Invasive Cardiol. 2019; 31(2): E9–E14.
    PubMed
  6. Spence J, LeManach Y, Chan MTV, et al. Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019; 191(30): E830–E837.
    CrossRefPubMed
  7. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012; 380(9847): 1059–1065.
    CrossRefPubMed
  8. Sazgary L, Puelacher C, Buse GL, et al. Incidence of major adverse cardiac events following non-cardiac surgery. Eur Heart J Acute Cardiovasc Care. 2020; 10(5): 550–558.
    CrossRefPubMed
  9. Smilowitz NR, Berger JS. Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review. JAMA. 2020; 324(3): 279–290.
    CrossRefPubMed
  10. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35(35): 2383–2431.
    CrossRefPubMed
  11. Kamel H, Johnston SC, Kirkham JC, et al. Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation. 2012; 126(2): 207–212.
    CrossRefPubMed
  12. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734): 23–32.
    CrossRefPubMed
  13. Kougias P, Sharath S, Barshes NR, et al. Effect of postoperative anemia and baseline cardiac risk on serious adverse outcomes after major vascular interventions. J Vasc Surg. 2017; 66(6): 1836–1843.
    CrossRefPubMed
  14. Cohn SL. The cardiac consult for patients undergoing non-cardiac surgery. Heart. 2016; 102(16): 1322–1332.
    CrossRefPubMed
  15. Guay J, Choi P, Suresh S, et al. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014(1): CD010108.
    CrossRefPubMed
  16. Norderud K, Egholm G, Thim T, et al. Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation. Eur Heart J Qual Care Clin Outcomes. 2019; 5(1): 22–27.
    CrossRefPubMed
  17. Mangano DT. Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth. 2004; 18(1): 1–6.
    CrossRefPubMed
  18. Glance LG, Lustik SJ, Hannan EL, et al. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012; 255(4): 696–702.
    CrossRefPubMed
  19. Müller MD, Lyrer P, Brown MM, et al. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database Syst Rev. 2020; 2: CD000515.
    CrossRefPubMed
  20. Bendixen M, Jørgensen OD, Kronborg C, et al. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial. Lancet Oncol. 2016; 17(6): 836–844.
    CrossRefPubMed
  21. Falcoz PE, Puyraveau M, Thomas PA, et al. ESTS Database Committee and ESTS Minimally Invasive Interest Group. Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg. 2016; 49(2): 602–609.
    CrossRefPubMed
  22. Martin D, Mantziari S, Demartines N, et al. ESA Study Group. Defining Major Surgery: A Delphi Consensus Among European Surgical Association (ESA) Members. World J Surg. 2020; 44(7): 2211–2219.
    CrossRefPubMed
  23. Bolliger M, Kroehnert JA, Molineus F, et al. Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients. Eur Surg. 2018; 50(6): 256–261.
    CrossRefPubMed
  24. Björck M, Earnshaw JJ, Acosta S, et al. Editor's Choice — European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the management of acute limb ischaemia. Eur J Vasc Endovasc Surg. 2020; 59(2): 173–218.
    CrossRefPubMed
  25. Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg. 2000; 87(11): 1480–1493.
    CrossRefPubMed
  26. Popescu WM, Bell R, Duffy AJ, et al. A pilot study of patients with clinically severe obesity undergoing laparoscopic surgery: evidence for impaired cardiac performance. J Cardiothorac Vasc Anesth. 2011; 25(6): 943–949.
    CrossRefPubMed
  27. Lestar M, Gunnarsson L, Lagerstrand L, et al. Hemodynamic perturbations during robot-assisted laparoscopic radical prostatectomy in 45° Trendelenburg position. Anesth Analg. 2011; 113(5): 1069–1075.
    CrossRefPubMed
  28. Hirvonen EA, Nuutinen LS, Kauko M. Hemodynamic changes due to Trendelenburg positioning and pneumoperitoneum during laparoscopic hysterectomy. Acta Anaesthesiol Scand. 1995; 39(7): 949–955.
    CrossRefPubMed
  29. Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Ann Surg. 2005; 241(2): 219–226.
    CrossRefPubMed
  30. Keus F, Gooszen HG, van Laarhoven CJ. Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database Syst Rev. 2010(1): CD008318.
    CrossRefPubMed
  31. Mamidanna R, Burns EM, Bottle A, et al. Reduced risk of medical morbidity and mortality in patients selected for laparoscopic colorectal resection in England: a population-based study. Arch Surg. 2012; 147(3): 219–227.
    CrossRefPubMed
  32. Cirocchi R, Farinella E, Trastulli S, et al. Elective sigmoid colectomy for diverticular disease. Laparoscopic vs open surgery: a systematic review. Colorectal Dis. 2012; 14(6): 671–683.
    CrossRefPubMed
  33. Murr MM, Martin T, Haines K, et al. A state-wide review of contemporary outcomes of gastric bypass in Florida: does provider volume impact outcomes? Ann Surg. 2007; 245(5): 699–706.
    CrossRefPubMed
  34. Grailey K, Markar SR, Karthikesalingam A, et al. Laparoscopic versus open colorectal resection in the elderly population. Surg Endosc. 2013; 27(1): 19–30.
    CrossRefPubMed
  35. Wanhainen A, Verzini F, Van Herzeele I, et al. Editor's Choice — European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2019; 57(1): 8–93.
    CrossRefPubMed
  36. Powell JT, Sweeting MJ, Ulug P, et al. Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. Br J Surg. 2017; 104(3): 166–178.
    CrossRefPubMed
  37. Lederle FA, Kyriakides TC, Stroupe KT, et al. Open versus endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2019; 380(22): 2126–2135.
    CrossRefPubMed
  38. Bauer SM, Cayne NS, Veith FJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg. 2010; 51(1): 242–251.
    CrossRefPubMed
  39. Antoniou GA, Chalmers N, Georgiadis GS, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg. 2013; 57(1): 242–253.
    CrossRefPubMed
  40. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227–3337.
    CrossRefPubMed
  41. Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014; 120(3): 564–578.
    CrossRefPubMed
  42. Noordzij PG, Boersma E, Bax JJ, et al. Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery. Am J Cardiol. 2006; 97(7): 1103–1106.
    CrossRefPubMed
  43. Chivulescu M, Lie ØH, Popescu BA, et al. High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy. Eur Heart J. 2020; 41(14): 1401–1410.
    CrossRefPubMed
  44. Hallqvist L, Granath F, Bell M. Myocardial infarction after noncardiac surgery in Sweden: a national, retrospective observational cohort study. Br J Anaesth. 2020; 125(1): 47–54.
    CrossRefPubMed
  45. Chaudhry W, Cohen MC. Cardiac screening in the noncardiac surgery patient. Surg Clin North Am. 2017; 97(4): 717–732.
    CrossRefPubMed
  46. Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med. 2010; 152(1): 26–35.
    CrossRefPubMed
  47. Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017; 33(1): 17–32.
    CrossRefPubMed
  48. Yap MaK, Ang KF, Gonzales-Porciuncula LA, et al. Validation of the American College of Surgeons Risk Calculator for preoperative risk stratification. Heart Asia. 2018; 10(2): e010993.
    CrossRefPubMed
  49. Dakik HA, Chehab O, Eldirani M, et al. A new index for pre-operative cardiovascular evaluation. J Am Coll Cardiol. 2019; 73(24): 3067–3078.
    CrossRefPubMed
  50. Dakik HA, Sbaity E, Msheik A, et al. AUB-HAS2 Cardiovascular Risk Index: performance in surgical subpopulations and comparison to the Revised Cardiac Risk Index. J Am Heart Assoc. 2020; 9(10): e016228.
    CrossRefPubMed
  51. Dakik HA, Eldirani M, Kaspar C, et al. Prospective validation of the AUB-HAS2 cardiovascular risk index. Eur Heart J Qual Care Clin Outcomes. 2022; 8(1): 96–97.
    CrossRefPubMed
  52. Duceppe E, Patel A, Chan MTV, et al. Preoperative N-terminal pro-B-type natriuretic peptide and cardiovascular events after noncardiac surgery: a cohort study. Ann Intern Med. 2020; 172(2): 96–104.
    CrossRefPubMed
  53. Weber M, Luchner A, Seeberger M, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J. 2013; 34(11): 853–862.
    CrossRefPubMed
  54. Kueh SH, Pasley T, Wheeler M, et al. The not so innocent heart murmur: a 5-year experience. Intern Med J. 2017; 47(2): 199–205.
    CrossRefPubMed
  55. Douglas PS, Garcia MJ, Haines DE, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr. 2011; 24(3): 229–267.
    CrossRefPubMed
  56. Friedman JM, Couso R, Kitchens M, et al. Benign heart murmurs as a predictor for complications following total joint arthroplasty. J Orthop. 2017; 14(4): 470–474.
    CrossRefPubMed
  57. Hip Attack Investigators. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial. Lancet. 2020; 395(10225): 698–708.
    CrossRefPubMed
  58. Cowie B. The preoperative patient with a systolic murmur. Anesth Pain Med. 2015; 5(6): e32105.
    CrossRefPubMed
  59. Attenhofer JC, Turina J, Mayer K, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med. 2000; 108(8): 614–620.
    CrossRefPubMed
  60. Kobal SL, Trento L, Baharami S, et al. Comparison of effectiveness of hand-carried ultrasound to bedside cardiovascular physical examination. Am J Cardiol. 2005; 96(7): 1002–1006.
    CrossRefPubMed
  61. Abidov A, Rozanski A, Hachamovitch R, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med. 2005; 353(18): 1889–1898.
    CrossRefPubMed
  62. Cajita MI, Cajita TR, Han HR. Health literacy and heart failure: a systematic review. J Cardiovasc Nurs. 2016; 31(2): 121–130.
    CrossRefPubMed
  63. Magnani JW, Mujahid MS, Aronow HD, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association. Circulation. 2018; 138(2): e48–e74.
    CrossRefPubMed
  64. Shinkunas LA, Klipowicz CJ, Carlisle EM. Shared decision making in surgery: a scoping review of patient and surgeon preferences. BMC Med Inform Decis Mak. 2020; 20(1): 190.
    CrossRefPubMed
  65. de Mik SML, Stubenrouch FE, Balm R, et al. Systematic review of shared decision-making in surgery. Br J Surg. 2018; 105(13): 1721–1730.
    CrossRefPubMed
  66. Pham C, Lizarondo L, Karnon J, et al. Strategies for implementing shared decision making in elective surgery by health care practitioners: A systematic review. J Eval Clin Pract. 2020; 26(2): 582–601.
    CrossRefPubMed
  67. Niburski K, Guadagno E, Abbasgholizadeh-Rahimi S, et al. Shared decision making in surgery: a meta-analysis of existing literature. Patient. 2020; 13(6): 667–681.
    CrossRefPubMed
  68. Abate S, Chekol Y, Basu B. Global prevalence and determinants of preoperative anxiety among surgical patients: A systematic review and meta-analysis. Int J Surg Open. 2020; 25: 6–16.
    CrossRef
  69. Takagi H, Ando T, Umemoto T, et al. ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Perioperative depression or anxiety and postoperative mortality in cardiac surgery: a systematic review and meta-analysis. Heart Vessels. 2017; 32(12): 1458–1468.
    CrossRefPubMed
  70. Tully PJ, Baker RA. Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review. J Geriatr Cardiol. 2012; 9(2): 197–208.
    CrossRefPubMed
  71. Rosenberger PH, Jokl P, Ickovics J. Psychosocial factors and surgical outcomes: an evidence-based literature review. J Am Acad Orthop Surg. 2006; 14(7): 397–405.
    CrossRefPubMed
  72. Theunissen M, Peters ML, Bruce J, et al. Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain. Clin J Pain. 2012; 28(9): 819–841.
    CrossRefPubMed
  73. Szeverenyi C, Kekecs Z, Johnson A, et al. The use of adjunct psychosocial interventions can decrease postoperative pain and improve the quality of clinical care in orthopedic surgery: a systematic review and meta-analysis of randomized controlled trials. J Pain. 2018; 19(11): 1231–1252.
    CrossRefPubMed
  74. Villa G, Lanini I, Amass T, et al. Effects of psychological interventions on anxiety and pain in patients undergoing major elective abdominal surgery: a systematic review. Perioper Med (Lond). 2020; 9(1): 38.
    CrossRefPubMed
  75. Richards SH, Anderson L, Jenkinson CE, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2017; 4: CD002902.
    CrossRefPubMed
  76. Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013; 217(5): 833–842.e1-3.
    CrossRefPubMed
  77. Bertges DJ, Goodney PP, Zhao Y, et al. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg. 2010; 52(3): 674–683.e3.
    CrossRefPubMed
  78. Protopapa KL, Simpson JC, Smith NCE, et al. Development and validation of the Surgical Outcome Risk Tool (SORT). Br J Surg. 2014; 101(13): 1774–1783.
    CrossRefPubMed
  79. Wong DJN, Harris S, Sahni A, et al. Developing and validating subjective and objective risk-assessment measures for predicting mortality after major surgery: An international prospective cohort study. PLoS Med. 2020; 17(10): e1003253.
    CrossRefPubMed
  80. Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011; 124(4): 381–387.
    CrossRefPubMed
  81. Msheik A, Kaspar C, Mailhac A, et al. Performance of the AUB-HAS2 Cardiovascular Risk Index in vascular surgery patients. Vasc Med. 2021; 26(5): 535–541.
    CrossRefPubMed
  82. Glance LG, Faden E, Dutton RP, et al. Impact of the choice of risk model for identifying low-risk patients using the 2014 American College of Cardiology/American Heart Association Perioperative Guidelines. Anesthesiology. 2018; 129(5): 889–900.
    CrossRefPubMed
  83. Robinson TN, Walston JD, Brummel NE, et al. Frailty for surgeons: review of a national institute on aging conference on frailty for specialists. J Am Coll Surg. 2015; 221(6): 1083–1092.
    CrossRefPubMed
  84. Richter D, Guasti L, Walker D, et al. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol. 2022; 29(1): 216–227.
    CrossRefPubMed
  85. Hornor MA, Ma M, Zhou L, et al. Enhancing the American College of Surgeons NSQIP Surgical Risk Calculator to predict geriatric outcomes. J Am Coll Surg. 2020; 230(1): 88–100.e1.
    CrossRefPubMed
  86. Tjeertes EKM, van Fessem JMK, Mattace-Raso FUS, et al. Influence of frailty on outcome in older patients undergoing non-cardiac surgery - a systematic review and meta-analysis. Aging Dis. 2020; 11(5): 1276–1290.
    CrossRefPubMed
  87. Mosquera C, Spaniolas K, Fitzgerald TL. Impact of frailty on surgical outcomes: The right patient for the right procedure. Surgery. 2016; 160(2): 272–280.
    CrossRefPubMed
  88. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173(5): 489–495.
    CrossRefPubMed
  89. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M146–M156.
    CrossRefPubMed
  90. Alvarez-Nebreda ML, Bentov N, Urman RD, et al. Recommendations for preoperative management of frailty from the Society for Perioperative Assessment and Quality Improvement (SPAQI). J Clin Anesth. 2018; 47: 33–42.
    CrossRefPubMed
  91. Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma. 2014; 28(3): e49–e55.
    CrossRefPubMed
  92. Borson S, Scanlan JM, Chen P, et al. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003; 51(10): 1451–1454.
    CrossRefPubMed
  93. Biccard BM. Relationship between the inability to climb two flights of stairs and outcome after major non-cardiac surgery: implications for the pre-operative assessment of functional capacity. Anaesthesia. 2005; 60(6): 588–593.
    CrossRefPubMed
  94. Lurati Buse GAL, Puelacher C, Gualandro DM, et al. BASEL-PMI Investigators. Association between self-reported functional capacity and major adverse cardiac events in patients at elevated risk undergoing noncardiac surgery: a prospective diagnostic cohort study. Br J Anaesth. 2021; 126(1): 102–110.
    CrossRefPubMed
  95. Wijeysundera DN, Pearse RM, Shulman MA, et al. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. Lancet. 2018; 391(10140): 2631–2640.
    CrossRefPubMed
  96. Wijeysundera DN, Beattie WS, Hillis GS, et al. Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study. Br J Anaesth. 2020; 124(3): 261–270.
    CrossRefPubMed
  97. Jeger RV, Probst C, Arsenic R, et al. Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J. 2006; 151(2): 508–513.
    CrossRefPubMed
  98. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021; 42(14): 1289–1367.
    CrossRefPubMed
  99. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021; 42(5): 373–498.
    CrossRefPubMed
  100. Ganguli I, Lupo C, Mainor AJ, et al. Prevalence and cost of care cascades after low-value preoperative electrocardiogram for cataract surgery in fee-for-service medicare beneficiaries. JAMA Intern Med. 2019; 179(9): 1211–1219.
    CrossRefPubMed
  101. Gualandro DM, Puelacher C, LuratiBuse G, et al. Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery. Am Heart J. 2018; 203: 67–73.
    CrossRefPubMed
  102. Humble CAS, Huang S, Jammer Ib, et al. Prognostic performance of preoperative cardiac troponin and perioperative changes in cardiac troponin for the prediction of major adverse cardiac events and mortality in noncardiac surgery: A systematic review and meta-analysis. PLoS One. 2019; 14(4): e0215094.
    CrossRefPubMed
  103. Park SJ, Choi JH, Cho SJ, et al. Comparison of transthoracic echocardiography with N-terminal pro-brain natriuretic Peptide as a tool for risk stratification of patients undergoing major noncardiac surgery. Korean Circ J. 2011; 41(9): 505–511.
    CrossRefPubMed
  104. Lee G, Sou SM, Twerenbold R, et al. B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia. Am J Med. 2014; 127(5): 427–435.
    CrossRefPubMed
  105. Walter J, du Fay de Lavallaz J, Koechlin L, et al. Using high-sensitivity cardiac troponin for the exclusion of inducible myocardial ischemia in symptomatic patients: a cohort study. Ann Intern Med. 2020; 172(3): 175–185.
    CrossRefPubMed
  106. Walter JE, Honegger U, Puelacher C, et al. Prospective validation of a biomarker-based rule out strategy for functionally relevant coronary artery disease. Clin Chem. 2018; 64(2): 386–395.
    CrossRefPubMed
  107. Mueller D, Puelacher C, Honegger U, et al. Direct comparison of cardiac troponin t and i using a uniform and a sex-specific approach in the detection of functionally relevant coronary artery disease. Clin Chem. 2018; 64(11): 1596–1606.
    CrossRefPubMed
  108. Ackland GL, Abbott TEF, Cain D, et al. Preoperative systemic inflammation and perioperative myocardial injury: prospective observational multicentre cohort study of patients undergoing non-cardiac surgery. Br J Anaesth. 2019; 122(2): 180–187.
    CrossRefPubMed
  109. Devereaux PJ, Biccard BM, Sigamani A, et al. Writing Committee for the VISION Study Investigators. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017; 317(16): 1642–1651.
    CrossRefPubMed
  110. Puelacher C, Gualandro DM, Lurati Buse G, et al. Etiology of peri-operative myocardial infarction/injury after noncardiac surgery and associated outcome. J Am Coll Cardiol. 2020; 76(16): 1910–1912.
    CrossRefPubMed
  111. Puelacher C, Lurati Buse G, Seeberger D, et al. Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization. Circulation. 2018; 137(12): 1221–1232.
    CrossRefPubMed
  112. Huelsmann M, Neuhold S, Resl M, et al. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial. J Am Coll Cardiol. 2013; 62(15): 1365–1372.
    CrossRefPubMed
  113. Ledwidge M, Gallagher J, Conlon C, et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA. 2013; 310(1): 66–74.
    CrossRefPubMed
  114. Mueller C, McDonald K, de Boer RA, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019; 21(6): 715–731.
    CrossRefPubMed
  115. De Hert SG, Lurati Buse GA. Cardiac biomarkers for the prediction and detection of adverse cardiac events after noncardiac surgery: a narrative review. Anesth Analg. 2020; 131(1): 187–195.
    CrossRefPubMed
  116. Mauermann E, Bolliger D, Seeberger E, et al. Incremental value of preoperative copeptin for predicting myocardial injury. Anesth Analg. 2016; 123(6): 1363–1371.
    CrossRefPubMed
  117. Buse GL, Manns B, Lamy A, et al. Troponin T monitoring to detect myocardial injury after noncardiac surgery: a cost-consequence analysis. Can J Surg. 2018; 61(3): 185–194.
    CrossRefPubMed
  118. Devereaux PJ, Chan MTV, Alonso-Coello P, et al. Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012; 307(21): 2295–2304.
    CrossRefPubMed
  119. Mantha S, Foss J, Ellis JE, et al. Intense cardiac troponin surveillance for long-term benefits is cost-effective in patients undergoing open abdominal aortic surgery: a decision analysis model. Anesth Analg. 2007; 105(5): 1346–1356.
    CrossRefPubMed
  120. Levitan EB, Graham LA, Valle JA, et al. Pre-operative echocardiography among patients with coronary artery disease in the United States Veterans Affairs healthcare system: A retrospective cohort study. BMC Cardiovasc Disord. 2016; 16(1): 173.
    CrossRefPubMed
  121. Chang HY, Chang WT, Liu YW. Application of transthoracic echocardiography in patients receiving intermediate- or high-risk noncardiac surgery. PLoS One. 2019; 14(4): e0215854.
    CrossRefPubMed
  122. Wijeysundera DN, Beattie WS, Karkouti K, et al. Association of echocardiography before major elective non-cardiac surgery with postoperative survival and length of hospital stay: population based cohort study. BMJ. 2011; 342: d3695.
    CrossRefPubMed
  123. Faris JG, Hartley K, Fuller CM, et al. Audit of cardiac pathology detection using a criteria-based perioperative echocardiography service. Anaesth Intensive Care. 2012; 40(4): 702–709.
    CrossRefPubMed
  124. Steeds RP, Garbi M, Cardim N, et al. EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review. Eur Heart J Cardiovasc Imaging. 2017; 18(11): 1191–1204.
    CrossRefPubMed
  125. Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. 2003; 89(11): 1327–1334.
    CrossRefPubMed
  126. Halm EA, Browner WS, Tubau JF, et al. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med. 1996; 125(6): 433–441.
    CrossRefPubMed
  127. Rohde L, Polanczyk C, Goldman L, et al. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol. 2001; 87(5): 505–509.
    CrossRefPubMed
  128. Galasko GIW, Barnes SC, Collinson P, et al. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J. 2006; 27(2): 193–200.
    CrossRefPubMed
  129. Cardim N, Dalen H, Voigt JU, et al. The use of handheld ultrasound devices: a position statement of the European Association of Cardiovascular Imaging (2018 update). Eur Heart J Cardiovasc Imaging. 2019; 20(3): 245–252.
    CrossRefPubMed
  130. Canty DJ, Royse CF, Kilpatrick D, et al. The impact of focused transthoracic echocardiography in the pre-operative clinic. Anaesthesia. 2012; 67(6): 618–625.
    CrossRefPubMed
  131. Heiberg J, El-Ansary D, Canty DJ, et al. Focused echocardiography: a systematic review of diagnostic and clinical decision-making in anaesthesia and critical care. Anaesthesia. 2016; 71(9): 1091–1100.
    CrossRefPubMed
  132. Canty DJ, Royse CF. Audit of anaesthetist-performed echocardiography on perioperative management decisions for non-cardiac surgery. Br J Anaesth. 2009; 103(3): 352–358.
    CrossRefPubMed
  133. Canty DJ, Heiberg J, Yang Y, et al. One-year results of the pilot multicentre randomised trial of preoperative focused cardiac ultrasound in hip fracture surgery. Anaesth Intensive Care. 2019; 47(2): 207–208.
    CrossRefPubMed
  134. Matyal R, Hess PE, Subramaniam B, et al. Perioperative diastolic dysfunction during vascular surgery and its association with postoperative outcome. J Vasc Surg. 2009; 50(1): 70–76.
    CrossRefPubMed
  135. Saito S, Takagi A, Kurokawa F, et al. Usefulness of tissue Doppler echocardiography to predict perioperative cardiac events in patients undergoing noncardiac surgery. Heart Vessels. 2012; 27(6): 594–602.
    CrossRefPubMed
  136. Higashi M, Yamaura K, Ikeda M, et al. Diastolic dysfunction of the left ventricle is associated with pulmonary edema after renal transplantation. Acta Anaesthesiol Scand. 2013; 57(9): 1154–1160.
    CrossRefPubMed
  137. Brecher O, Gulati H, Roistacher N, et al. Preoperative echocardiographic indices of diastolic dysfunction and brain natriuretic peptide in predicting postoperative atrial fibrillation after noncardiac surgery. Anesth Analg. 2017; 124(4): 1099–1104.
    CrossRefPubMed
  138. Zhou Y, Liu L, Cheng T, et al. Grade 3 echocardiographic diastolic dysfunction is associated with increased risk of major adverse cardiovascular events after surgery: a retrospective cohort study. Anesth Analg. 2019; 129(3): 651–658.
    CrossRefPubMed
  139. Fayad A, Ansari MT, Yang H, et al. Perioperative diastolic dysfunction in patients undergoing noncardiac surgery is an independent risk factor for cardiovascular events: a systematic review and meta-analysis. Anesthesiology. 2016; 125(1): 72–91.
    CrossRefPubMed
  140. Willingham M, Ayoubi SAl-, Doan M, et al. Preoperative diastolic dysfunction and postoperative outcomes after noncardiac surgery. J Cardiothorac Vasc Anesth. 2020; 34(3): 679–686.
    CrossRefPubMed
  141. Sougawa H, Ino Y, Kitabata H, et al. Impact of left ventricular ejection fraction and preoperative hemoglobin level on perioperative adverse cardiovascular events in noncardiac surgery. Heart Vessels. 2021; 36(9): 1317–1326.
    CrossRefPubMed
  142. Hreybe H, Zahid M, Sonel A, et al. Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy. Clin Cardiol. 2006; 29(2): 65–68.
    CrossRefPubMed
  143. Kertai MD, Bountioukos M, Boersma E, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med. 2004; 116(1): 8–13.
    CrossRefPubMed
  144. Marbach JA, Almufleh A, Di Santo P, et al. Comparative accuracy of focused cardiac ultrasonography and clinical examination for left ventricular dysfunction and valvular heart disease: a systematic review and meta-analysis. Ann Intern Med. 2019; 171(4): 264–272.
    CrossRefPubMed
  145. Lurati Buse GAL, Puelacher C, Gualandro DM, et al. Adherence to the European Society of Cardiology/European Society of Anaesthesiology recommendations on preoperative cardiac testing and association with positive results and cardiac events: a cohort study. Br J Anaesth. 2021; 127(3): 376–385.
    CrossRefPubMed
  146. Storey RF, Valgimigli M, Cuisset T, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
    CrossRefPubMed
  147. Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014; 63(4): 380–406.
    CrossRefPubMed
  148. Pellikka PA, Arruda-Olson A, Chaudhry FA, et al. Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography. J Am Soc Echocardiogr. 2020; 33(1): 1–41.e8.
    CrossRefPubMed
  149. Koh AS, Flores JLS, Keng FYJ, et al. Correlation between clinical outcomes and appropriateness grading for referral to myocardial perfusion imaging for preoperative evaluation prior to non-cardiac surgery. J Nucl Cardiol. 2012; 19(2): 277–284.
    CrossRefPubMed
  150. Nguyen P, Plotkin J, Fishbein TM, et al. Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular prognosis. Int J Cardiovasc Imaging. 2013; 29(8): 1741–1748.
    CrossRefPubMed
  151. Shaw LJ, Eagle KA, Gersh BJ, et al. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol. 1996; 27(4): 787–798.
    CrossRefPubMed
  152. Beattie WS, Abdelnaem E, Wijeysundera DN, et al. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg. 2006; 102(1): 8–16.
    CrossRefPubMed
  153. Bach DS, Eagle KA. Dobutamine stress echocardiography. Stressing the indications for preoperative testing. Circulation. 1997; 95(1): 8–10.
    CrossRefPubMed
  154. Etchells E, Meade M, Tomlinson G, et al. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. J Vasc Surg. 2002; 36(3): 534–540.
    CrossRefPubMed
  155. Ballal RS, Kapadia S, Secknus MA, et al. Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography. Am Heart J. 1999; 137(3): 469–475.
    CrossRefPubMed
  156. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA. 2001; 285(14): 1865–1873.
    CrossRefPubMed
  157. Cullen MW, McCully RB, Widmer RJ, et al. Preoperative dobutamine stress echocardiography and clinical factors for assessment of cardiac risk after noncardiac surgery. J Am Soc Echocardiogr. 2020; 33(4): 423–432.
    CrossRefPubMed
  158. Van Damme H, Piérard L, Gillain D, et al. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy. Cardiovasc Surg. 1997; 5(1): 54–64.
    CrossRefPubMed
  159. Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007; 49(2): 227–237.
    CrossRefPubMed
  160. Cohen MC, Siewers AE, Dickens JD, et al. Perioperative and long-term prognostic value of dipyridamole Tc-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery. J Nucl Cardiol. 2003; 10(5): 464–472.
    CrossRefPubMed
  161. Dowsley TF, Sheth T, Chow BJW. Complementary pre-operative risk assessment using coronary computed tomography angiography and nuclear myocardial perfusion imaging in non-cardiac surgery: A VISION-CTA sub-study. J Nucl Cardiol. 2020; 27(4): 1331–1337.
    CrossRefPubMed
  162. Das MK, Pellikka PA, Mahoney DW, et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol. 2000; 35(6): 1647–1653.
    CrossRefPubMed
  163. Torres MR, Short L, Baglin T, et al. Usefulness of clinical risk markers and ischemic threshold to stratify risk in patients undergoing major noncardiac surgery. Am J Cardiol. 2002; 90(3): 238–242.
    CrossRefPubMed
  164. Labib SB, Goldstein M, Kinnunen PM, et al. Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: importance of resting wall motion abnormalities. J Am Coll Cardiol. 2004; 44(1): 82–87.
    CrossRefPubMed
  165. Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2016; 17(11): 1191–1229.
    CrossRefPubMed
  166. Nandalur KR, Dwamena BA, Choudhri AF, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007; 50(14): 1343–1353.
    CrossRefPubMed
  167. Vavere AL, Arbab-Zadeh A, Rochitte CE, et al. Coronary artery stenoses: accuracy of 64-detector row CT angiography in segments with mild, moderate, or severe calcification — a subanalysis of the CORE-64 trial. Radiology. 2011; 261(1): 100–108.
    CrossRefPubMed
  168. Sheth T, Chan M, Butler C, et al. Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery: prospective cohort study. BMJ. 2015; 350: h1907.
    CrossRefPubMed
  169. Krievins D, Zellans E, Latkovskis G, et al. Diagnosis and management of silent coronary ischemia in patients undergoing carotid endarterectomy. J Vasc Surg. 2021; 73(2): 533–541.
    CrossRefPubMed
  170. Krievins D, Zellans E, Latkovskis G, et al. Pre-operative diagnosis of silent coronary ischaemia may reduce post-operative death and myocardial infarction and improve survival of patients undergoing lower extremity surgical revascularisation. Eur J Vasc Endovasc Surg. 2020; 60(3): 411–420.
    CrossRefPubMed
  171. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119–177.
    CrossRefPubMed
  172. Illuminati G, Ricco JB, Greco C, et al. Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2010; 39(2): 139–145.
    CrossRefPubMed
  173. Sørensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012; 147(4): 373–383.
    CrossRefPubMed
  174. Gourgiotis S, Aloizos S, Aravosita P, et al. The effects of tobacco smoking on the incidence and risk of intraoperative and postoperative complications in adults. Surgeon. 2011; 9(4): 225–232.
    CrossRefPubMed
  175. World Health Organization. WHO Tobacco and postsurgical outcomes. https://apps.who.int/iris/rest/bitstreams/1265388/retrieve.
  176. Mills E, Eyawo O, Lockhart I, et al. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med. 2011; 124(2): 144–154.e8.
    CrossRefPubMed
  177. Lee SM, Landry J, Jones PM, et al. Long-term quit rates after a perioperative smoking cessation randomized controlled trial. Anesth Analg. 2015; 120(3): 582–587.
    CrossRefPubMed
  178. Wong J, Abrishami A, Riazi S, et al. A perioperative smoking cessation intervention with varenicline, counseling, and fax referral to a telephone quitline versus a brief intervention: a randomized controlled trial. Anesth Analg. 2017; 125(2): 571–579.
    CrossRefPubMed
  179. Cavalheri V, Granger C. Preoperative exercise training for patients with non-small cell lung cancer. Cochrane Database Syst Rev. 2017; 6: CD012020.
    CrossRefPubMed
  180. Tew GA, Ayyash R, Durrand J, et al. Clinical guideline and recommendations on pre-operative exercise training in patients awaiting major non-cardiac surgery. Anaesthesia. 2018; 73(6): 750–768.
    CrossRefPubMed
  181. Musallam KM, Rosendaal FR, Zaatari G, et al. Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg. 2013; 148(8): 755–762.
    CrossRefPubMed
  182. Turan A, Mascha EJ, Roberman D, et al. Smoking and perioperative outcomes. Anesthesiology. 2011; 114(4): 837–846.
    CrossRefPubMed
  183. Im C, Oh TK, Song IA. Association between use of preoperative antihypertensive medication and 90-day mortality after noncardiac surgery: a retrospective cohort study. Am J Hypertens. 2020; 33(6): 534–542.
    CrossRefPubMed
  184. Clemente-Moragón A, Gómez M, Villena-Gutiérrez R, et al. Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation. Eur Heart J. 2020; 41(46): 4425–4440.
    CrossRefPubMed
  185. Devereaux PJ, Yang H, Yusuf S, et al. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371(9627): 1839–1847.
    CrossRefPubMed
  186. Alonso-Coello P, Paniagua P, Mizera R, et al. Should physicians initiate beta-blocker therapy in patients undergoing non-cardiac surgery? Insights from the POISE trial. Pol Arch Med Wewn. 2008; 118(11): 616–618.
    PubMed
  187. Blessberger H, Lewis SR, Pritchard MW, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2019; 9: CD013438.
    CrossRefPubMed
  188. Friedell ML, Van Way CW, Freyberg RW, et al. β-blockade and operative mortality in noncardiac surgery: harmful or helpful? JAMA Surg. 2015; 150(7): 658–663.
    CrossRefPubMed
  189. Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014; 64: 2406–2425.
    CrossRefPubMed
  190. London MJ, Hur K, Schwartz GG, et al. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013; 309(16): 1704–1713.
    CrossRefPubMed
  191. Angeli F, Verdecchia P, Karthikeyan G, et al. ß-blockers reduce mortality in patients undergoing high-risk non-cardiac surgery. Am J Cardiovasc Drugs. 2010; 10(4): 247–259.
    CrossRefPubMed
  192. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005; 353(4): 349–361.
    CrossRefPubMed
  193. Wallace AW, Au S, Cason BA. Perioperative β-blockade: atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology. 2011; 114(4): 824–836.
    CrossRefPubMed
  194. Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ. 2005; 331(7522): 932.
    CrossRefPubMed
  195. Ashes C, Judelman S, Wijeysundera DN, et al. Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients. Anesthesiology. 2013; 119(4): 777–787.
    CrossRefPubMed
  196. Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J. 2001; 141(1): 148–153.
    CrossRefPubMed
  197. Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative β-blockade and postoperative mortality. Anesthesiology. 2010; 113(4): 794–805.
    CrossRefPubMed
  198. Kwon S, Thompson R, Florence M, et al. β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program. Arch Surg. 2012; 147(5): 467–473.
    CrossRefPubMed
  199. Kertai MD, Cooter M, Pollard RJ, et al. Is compliance with Surgical Care Improvement Project Cardiac (SCIP-Card-2) measures for perioperative β-Blockers associated with reduced incidence of mortality and cardiovascular-related critical quality indicators after noncardiac surgery? Anesth Analg. 2018; 126(6): 1829–1838.
    CrossRefPubMed
  200. Longrois D, Couffignal C, Ait-Hamou N, et al. Indispensable optimisation de la réintroduction des bêtabloquants après chirurgie cardiaque. Résultats de l’étude Bêtabloquants Avant et Après Chirurgie Cardiaque (BBAACC). Anesthésie & Réanimation. 2015; 1: A248.
    CrossRef
  201. Oesterle A, Weber B, Tung R, et al. Preventing postoperative atrial fibrillation after noncardiac surgery: a meta-analysis. Am J Med. 2018; 131(7): 795–804.e5.
    CrossRefPubMed
  202. Aoki Y, Kawasaki Y, Ide K, et al. Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial. JA Clin Rep. 2020; 6(1): 34.
    CrossRefPubMed
  203. Aoyama H, Otsuka Y, Aoyama Y. Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection. Gen Thorac Cardiovasc Surg. 2016; 64(12): 735–741.
    CrossRefPubMed
  204. Ojima T, Nakamori M, Nakamura M, et al. Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer. Br J Surg. 2017; 104(8): 1003–1009.
    CrossRefPubMed
  205. Horikoshi Y, Goyagi T, Kudo R, et al. The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial. J Clin Anesth. 2017; 38: 111–116.
    CrossRefPubMed
  206. O'Brien B, Burrage PS, Ngai JY, et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the management of perioperative atrial fibrillation in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2019; 33(1): 12–26.
    CrossRefPubMed
  207. Zhu J, Wang C, Gao D, et al. Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. Intern Med J. 2012; 42(10): 1078–1087.
    CrossRefPubMed
  208. Auer J, Weber T, Berent R, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J. 2004; 147(4): 636–643.
    CrossRefPubMed
  209. London MJ, Schwartz GG, Hur K, et al. Association of perioperative statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern Med. 2017; 177(2): 231–242.
    CrossRefPubMed
  210. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004; 291(17): 2092–2099.
    CrossRefPubMed
  211. Berwanger O, de Barros E Silva PGM, Barbosa RR, et al. Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial. Am Heart J. 2017; 184: 88–96.
    CrossRefPubMed
  212. Sanders RD, Nicholson A, Lewis SR, et al. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev. 2013(7): CD009971.
    CrossRefPubMed
  213. Putzu A, de Carvalho E Silva CM, de Almeida JP, et al. Perioperative statin therapy in cardiac and non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2018; 8(1): 95.
    CrossRefPubMed
  214. Wesselink EM, Kappen TH, Torn HM, et al. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018; 121(4): 706–721.
    CrossRefPubMed
  215. Shiffermiller JF, Monson BJ, Vokoun CW, et al. Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI). J Hosp Med. 2018; 13(10): 661–667.
    CrossRefPubMed
  216. Roshanov PS, Rochwerg B, Patel A, et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology. 2017; 126(1): 16–27.
    CrossRefPubMed
  217. Hollmann C, Fernandes NL, Biccard BM. A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery. Anesth Analg. 2018; 127(3): 678–687.
    CrossRefPubMed
  218. McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014; 371(11): 993–1004.
    CrossRefPubMed
  219. Legrand M, Futier E, Leone M, et al. Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial). Trials. 2019; 20(1): 160.
    CrossRefPubMed
  220. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg. 2003; 97(3): 634–641.
    CrossRefPubMed
  221. Kertai MD, Westerhout CM, Varga KS, et al. Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery. Br J Anaesth. 2008; 101(4): 458–465.
    CrossRefPubMed
  222. Oliver MF, Goldman L, Julian DG, et al. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology. 1999; 91(4): 951–961.
    CrossRefPubMed
  223. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med. 2014; 370(16): 1504–1513.
    CrossRefPubMed
  224. Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr. 1996; 126(16): 666–673.
    PubMed
  225. Arora P, Pourafkari L, Visnjevac O, et al. Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery. Clin Chem Lab Med. 2017; 55(1): 145–153.
    CrossRefPubMed
  226. Tagawa M, Ogata Ai, Hamano T. Pre- and/or intra-operative prescription of diuretics, but not renin-angiotensin-system inhibitors, is significantly associated with acute kidney injury after non-cardiac surgery: a retrospective cohort study. PLoS One. 2015; 10(7): e0132507.
    CrossRefPubMed
  227. Lo Sapio P, Gensini GF, Bevilacqua S, et al. The role of ivabradine in the incidence of perioperative coronary complications in patients undergoing vascular surgery. Int J Cardiol. 2013; 168(4): 4352–4353.
    CrossRefPubMed
  228. Thiruvenkatarajan V, Meyer EJ, Nanjappa N, et al. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019; 123(1): 27–36.
    CrossRefPubMed
  229. Patoulias D, Manafis A, Mitas C, et al. Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis; from pathophysiology to clinical practice. Cardiovasc Hematol Disord Drug Targets. 2018; 18(2): 139–146.
    CrossRefPubMed
  230. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996; 335(23): 1713–1720.
    CrossRefPubMed
  231. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction? Surgery. 2005; 138(2): 171–179.
    CrossRefPubMed
  232. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology. 1998; 88(1): 7–17.
    CrossRefPubMed
  233. Bouri S, Shun-Shin MJ, Cole GD, et al. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014; 100(6): 456–464.
    CrossRefPubMed
  234. Hajibandeh S, Hajibandeh S, Antoniou SA, et al. Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis. Br J Anaesth. 2017; 118(1): 11–21.
    CrossRefPubMed
  235. Xia J, Qu Y, Yin C, et al. Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery. Cardiology. 2015; 131(1): 30–37.
    CrossRefPubMed
  236. McEvoy MD, Gupta R, Koepke EJ, et al. Perioperative Quality Initiative Consensus Statement on postoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019; 122(5): 575–586.
    CrossRefPubMed
  237. Ellenberger C, Tait G, Beattie WS. Chronic β blockade is associated with a better outcome after elective noncardiac surgery than acute β blockade: a single-center propensity-matched cohort study. Anesthesiology. 2011; 114(4): 817–823.
    CrossRefPubMed
  238. Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebocontrolled, multicenter trial with 1-year follow-up. Anesthesiology. 2007; 107(1): 33–44.
    CrossRefPubMed
  239. Faloye AO, Gebre MA, Bechtel AJ. Predicting cardiac risk in noncardiac surgery: a narrative review. J Anesth. 2021; 35(1): 122–129.
    CrossRefPubMed
  240. Steffel J, Collins R, Antz M, et al. 2021 European hHeart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021; 23(10): 1612–1676.
    CrossRefPubMed
  241. Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA. 2019; 321(3): 277–287.
    CrossRefPubMed
  242. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–2381.
    CrossRefPubMed
  243. Devereaux PJ, Mrkobrada M, Sessler D, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014; 370(16): 1494–1503.
    CrossRefPubMed
  244. Graham MM, Sessler DI, Parlow JL, et al. Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med. 2018; 168(4): 237–244.
    CrossRefPubMed
  245. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
    CrossRefPubMed
  246. Brouwer J, Nijenhuis V, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020; 383(15): 1447–1457.
    CrossRefPubMed
  247. Koo BK, Kang J, Park KW, et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet. 2021; 397(10293): 2487–2496.
    CrossRefPubMed
  248. Mehran R, Baber U, Sharma SK, et al. Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. 2019; 381(21): 2032–2042.
    CrossRefPubMed
  249. Vranckx P, Valgimigli M, Jüni P, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018; 392(10151): 940–949.
    CrossRefPubMed
  250. Watanabe H, Domei T, Morimoto T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA. 2019; 321(24): 2414–2427.
    CrossRefPubMed
  251. Berger PB, Kleiman NS, Pencina MJ, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010; 3(9): 920–927.
    CrossRefPubMed
  252. Saia F, Belotti LM, Guastaroba P, et al. Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery? Circ Cardiovasc Qual Outcomes. 2016; 9(1): 39–47.
    CrossRefPubMed
  253. Huber KC, Evans MA, Bresnahan JF, et al. Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc. 1992; 67(1): 15–21.
    CrossRefPubMed
  254. Egholm G, Kristensen S, Thim T, et al. Risk associated with surgery within 12 months after coronary drug-eluting stent implantation. J Am Coll Cardiol. 2016; 68(24): 2622–2632.
    CrossRefPubMed
  255. Holcomb CN, Graham LA, Richman JS, et al. The incremental risk of coronary stents on postoperative adverse events: a matched cohort study. Ann Surg. 2016; 263(5): 924–930.
    CrossRefPubMed
  256. Mahmoud KD, Sanon S, Habermann EB, et al. Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery. J Am Coll Cardiol. 2016; 67(9): 1038–1049.
    CrossRefPubMed
  257. Holcomb CN, Hollis RH, Graham LA, et al. Association of coronary stent indication with postoperative outcomes following noncardiac surgery. JAMA Surg. 2016; 151(5): 462–469.
    CrossRefPubMed
  258. Rodriguez A, Guilera N, Mases A, et al. Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery: association with adverse events. Br J Anaesth. 2018; 120(1): 67–76.
    CrossRefPubMed
  259. Armstrong EJ, Graham L, Waldo SW, et al. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Catheter Cardiovasc Interv. 2017; 89(4): 617–627.
    CrossRefPubMed
  260. Siller-Matula JM, Petre A, Delle-Karth G, et al. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2017; 6(8): 753–770.
    CrossRefPubMed
  261. Mehran R, Baber U, Steg PG, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 2013; 382(9906): 1714–1722.
    CrossRefPubMed
  262. So DYF, Wells GA, Lordkipanidze M, Ruel M, Perrault LP, Yeong Chong A, et al. A randomized study of early vs. delayed coronary artery bypass surgery among patients with acute coronary syndromes treated with ticagrelor: the RAPID CABG study. http://clinicaltrialresults.org/wp-content/uploads/2021/11/So_RAPID_ CABG.pdf.
  263. Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009; 120(25): 2577–2585.
    CrossRefPubMed
  264. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018; 39(3): 213–260.
    CrossRefPubMed
  265. Valgimigli M, Frigoli E, Heg D, et al. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021; 385(18): 1643–1655.
    CrossRefPubMed
  266. Garot P, Morice MC, Tresukosol D, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015; 373(21): 2038–2047.
    CrossRefPubMed
  267. Windecker S, Latib A, Kedhi E, et al. Polymer-based or polymer-free stents in patients at high bleeding risk. N Engl J Med. 2020; 382(13): 1208–1218.
    CrossRefPubMed
  268. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165.
    CrossRefPubMed
  269. Watanabe H, Morimoto T, Natsuaki M, et al. Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial. JAMA Cardiol. 2022; 7(4): 407–417.
    CrossRefPubMed
  270. Kim BK, Hong MK, Shin DH, et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol. 2012; 60: 1340–1348.
  271. Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA. 2013; 310(23): 2510–2522.
    CrossRefPubMed
  272. Schulz-Schüpke S, Byrne RA, Ten Berg JM, et al. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J. 2015; 36(20): 1252–1263.
    CrossRefPubMed
  273. Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation. 2012; 125(3): 505–513.
    CrossRefPubMed
  274. Valgimigli M, Campo G, Monti M, et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation. 2012; 125(16): 2015–2026.
    CrossRefPubMed
  275. Han Y, Xu B, Xu K, et al. Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 trial. Circ Cardiovasc Interv. 2016; 9(2): e003145.
    CrossRefPubMed
  276. Hong SJ, Shin DH, Kim JS, et al. IVUS-XPL Investigators. 6-month versus 12-month dual-antiplatelet therapy following long everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JACC Cardiovasc Interv. 2016; 9(14): 1438–1446.
    CrossRefPubMed
  277. Hahn JY, Song YB, Oh JH, et al. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial. Lancet. 2018; 391(10127): 1274–1284.
    CrossRefPubMed
  278. Kedhi E, Fabris E, van der Ent M, et al. Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial. BMJ. 2018; 363: k3793.
    CrossRefPubMed
  279. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361(11): 1045–1057.
    CrossRefPubMed
  280. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357(20): 2001–2015.
    CrossRefPubMed
  281. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345(7): 494–502.
    CrossRefPubMed
  282. Sullivan AE, Nanna MG, Wang TY, et al. Bridging antiplatelet therapy after percutaneous coronary intervention: JACC review topic of the week. J Am Coll Cardiol. 2021; 78(15): 1550–1563.
    CrossRefPubMed
  283. Angheloiu GO, Gugiu GB, Ruse C, et al. Ticagrelor removal from human blood. JACC Basic Transl Sci. 2017; 2(2): 135–145.
    CrossRefPubMed
  284. Bhatt DL, Pollack CV, Weitz JI, et al. Antibody-based ticagrelor reversal agent in healthy volunteers. N Engl J Med. 2019; 380(19): 1825–1833.
    CrossRefPubMed
  285. Mahla E, Metzler H, Bornemann-Cimenti H, et al. Platelet inhibition and bleeding in patients undergoing non-cardiac surgery-the BIANCA Observational Study. Thromb Haemost. 2018; 118(5): 864–872.
    CrossRefPubMed
  286. Mahla E, Tantry US, Prüller F, et al. Is there a role for preoperative platelet function testing in patients undergoing cardiac surgery during antiplatelet therapy? Circulation. 2018; 138(19): 2145–2159.
    CrossRefPubMed
  287. Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv. 2012; 5(2): 261–269.
    CrossRefPubMed
  288. Windecker S, Lopes R, Massaro T, et al. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention. Circulation. 2019; 140(23): 1921–1932.
    CrossRefPubMed
  289. Généreux P, Rutledge DR, Palmerini T, et al. Stent thrombosis and dual antiplatelet therapy interruption with everolimus-eluting stents: insights from the xience v coronary stent system trials. Circ Cardiovasc Interv. 2015; 8(5): e001362.
    CrossRefPubMed
  290. Beyer-Westendorf J, Gelbricht V, Förster K, et al. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J. 2014; 35(28): 1888–1896.
    CrossRefPubMed
  291. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5): e35–e71.
    CrossRefPubMed
  292. Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015; 373(9): 823–833.
    CrossRefPubMed
  293. Kuo HC, Liu FL, Chen JT, et al. Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta-analysis. Clin Cardiol. 2020; 43(5): 441–449.
    CrossRefPubMed
  294. Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021; 373: n1205.
    CrossRefPubMed
  295. Caldeira D, David C, Santos AT, et al. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis. J Thromb Haemost. 2014; 12(5): 650–659.
    CrossRefPubMed
  296. Birnie DH, Healey JS, Wells GA, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013; 368(22): 2084–2093.
    CrossRefPubMed
  297. Sant'anna RT, Leiria TL, Nascimento T, et al. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study. Pacing Clin Electrophysiol. 2015; 38(4): 417–423.
    CrossRefPubMed
  298. Eichhorn W, Barsukov E, Al-Dam A, et al. Postoperative bleeding risk for cutaneous surgery in the head and neck region with continued phenprocoumon therapy. J Craniomaxillofac Surg. 2014; 42(5): 608–611.
    CrossRefPubMed
  299. Nandoe Tewarie RDS, Bartels RH. The perioperative use of oral anticoagulants during surgical procedures for carpal tunnel syndrome. A preliminary study. Acta Neurochir (Wien). 2010; 152(7): 1211–1213.
    CrossRefPubMed
  300. Doherty JU, Gluckman TyJ, Hucker WJ, et al. 2017 ACC Expert Consensus Decision Pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol. 2017; 69(7): 871–898.
    CrossRefPubMed
  301. Chai-Adisaksopha C, Hillis C, Siegal DM, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost. 2016; 116(5): 879–890.
    CrossRefPubMed
  302. Levy JH, Ageno W, Chan NC, et al. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2016; 14(3): 623–627.
    CrossRefPubMed
  303. Pollack CV, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med. 2017; 377(5): 431–441.
    CrossRefPubMed
  304. Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor xa inhibitors. N Engl J Med. 2019; 380(14): 1326–1335.
    CrossRefPubMed
  305. Majeed A, Ågren A, Holmström M, et al. Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study. Blood. 2017; 130(15): 1706–1712.
    CrossRefPubMed
  306. Healey JS, Eikelboom J, Yang S, et al. RE-LY Investigators. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation. 2012; 126(3): 343–348.
    CrossRefPubMed
  307. Garcia D, Alexander JH, Wallentin L, et al. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood. 2014; 124(25): 3692–3698.
    CrossRefPubMed
  308. Sherwood MW, Douketis JD, Patel MR, et al. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation. 2014; 129(18): 1850–1859.
    CrossRefPubMed
  309. Shaw JR, Li Na, Vanassche T, et al. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Adv. 2020; 4(15): 3520–3527.
    CrossRefPubMed
  310. Godier A, Dincq AS, Martin AC, et al. Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. Eur Heart J. 2017; 38(31): 2431–2439.
    CrossRefPubMed
  311. Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019; 179(11): 1469–1478.
    CrossRefPubMed
  312. Colonna P, von Heymann C, Santamaria A, et al. Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study. Clin Cardiol. 2020; 43(7): 769–780.
    CrossRefPubMed
  313. Albaladejo P, Pernod G, Godier A, et al. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016. Anaesth Crit Care Pain Med. 2018; 37(4): 391–399.
    CrossRefPubMed
  314. Narouze S, Benzon HT, Provenzano DA, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2015; 40(3): 182–212.
    CrossRefPubMed
  315. Johnston S. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery. Int J Oral Maxillofac Surg. 2016; 45(5): 618–630.
    CrossRefPubMed
  316. Sivolella S, De Biagi M, Brunello G, et al. Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants. Odontology. 2015; 103(3): 258–263.
    CrossRefPubMed
  317. Ockerman A, Vanhaverbeke M, Miclotte I, et al. Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trial. Br J Oral Maxillofac Surg. 2019; 57(10): 1107–1112.
    CrossRefPubMed
  318. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020; 382(18): 1696–1707.
    CrossRefPubMed
  319. Xu K, Chan NC, Ibrahim Q, et al. Reduction in mortality following elective major hip and knee surgery: a systematic review and meta-analysis. Thromb Haemost. 2019; 119(4): 668–674.
    CrossRefPubMed
  320. Smilowitz NR, Gupta N, Guo Yu, et al. Trends in perioperative venous thromboembolism associated with major noncardiac surgery. TH Open. 2017; 1(2): e82–e91.
    CrossRefPubMed
  321. Klemen ND, Feingold PL, Hashimoto B, et al. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. Lancet Haematol. 2020; 7(8): e583–e593.
    CrossRefPubMed
  322. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007; 45(2): 335–341.
    CrossRefPubMed
  323. Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010; 199(1 Suppl): S3–10.
    CrossRefPubMed
  324. Obi AT, Pannucci CJ, Nackashi A, et al. Validation of the Caprini venous thromboembolism risk assessment model in critically ill surgical patients. JAMA Surg. 2015; 150(10): 941–948.
    CrossRefPubMed
  325. Lobastov K, Barinov V, Schastlivtsev I, et al. Validation of the Caprini risk assessment model for venous thromboembolism in high-risk surgical patients in the background of standard prophylaxis. J Vasc Surg Venous Lymphat Disord. 2016; 4(2): 153–160.
    CrossRefPubMed
  326. Hachey KJ, Hewes PD, Porter LP, et al. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer. J Thorac Cardiovasc Surg. 2016; 151(1): 37–44.e1.
    CrossRefPubMed
  327. Sterbling HM, Rosen AK, Hachey KJ, et al. Caprini risk model decreases venous thromboembolism rates in thoracic surgery cancer patients. Ann Thorac Surg. 2018; 105(3): 879–885.
    CrossRefPubMed
  328. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(Suppl 2): e278S–e325S.
    CrossRefPubMed
  329. Faraoni D, Comes RF, Geerts W, et al. European guidelines on perioperative venous thromboembolism prophylaxis: neurosurgery. Eur J Anaesthesiol. 2018; 35(2): 90–95.
    CrossRefPubMed
  330. Kozek-Langenecker S, Fenger-Eriksen C, Thienpont E, et al. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the elderly. Eur J Anaesthesiol. 2018; 35(2): 116–122.
    CrossRefPubMed
  331. Venclauskas L, Maleckas A, Arcelus JI, et al. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the obese patient. Eur J Anaesthesiol. 2018; 35(2): 147–153.
    CrossRefPubMed
  332. Afshari A, Ageno W, Ahmed A, et al. European Guidelines on perioperative venous thromboembolism prophylaxis: Executive summary. Eur J Anaesthesiol. 2018; 35(2): 77–83.
    CrossRefPubMed
  333. Cimminiello C, Prandoni P, Agnelli G, et al. Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis. Intern Emerg Med. 2017; 12(8): 1291–1305.
    CrossRefPubMed
  334. Lassen MR, Gallus A, Raskob GE, et al. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010; 363(26): 2487–2498.
    CrossRefPubMed
  335. Lassen MR, Raskob GE, Gallus A, et al. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med. 2009; 361(6): 594–604.
    CrossRefPubMed
  336. Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008; 358(26): 2776–2786.
    CrossRefPubMed
  337. Eriksson BI, Borris LC, Friedman RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008; 358(26): 2765–2775.
    CrossRefPubMed
  338. Friedman RJ, Dahl OE, Rosencher N, et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010; 126(3): 175–182.
    CrossRefPubMed
  339. Kawai Y, Fuji T, Fujita S, et al. Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials. Thromb J. 2016; 14: 48.
    CrossRefPubMed
  340. Petersen PB, Kehlet H, Jørgensen CC, et al. Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Safety of in-hospital only thromboprophylaxis after fast-track total hip and knee arthroplasty: a prospective follow-up study in 17,582 procedures. Thromb Haemost. 2018; 118(12): 2152–2161.
    CrossRefPubMed
  341. Wilson DGG, Poole WEC, Chauhan SK, et al. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty. Bone Joint J. 2016; 98-B(8): 1056–1061.
    CrossRefPubMed
  342. Jenny JY, Pabinger I, Samama CM, et al. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: Aspirin. Eur J Anaesthesiol. 2018; 35(2): 123–129.
    CrossRefPubMed
  343. Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018; 378(8): 699–707.
    CrossRefPubMed
  344. Cassidy MR, Rosenkranz P, McAneny D. Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program. J Am Coll Surg. 2014; 218(6): 1095–1104.
    CrossRefPubMed
  345. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011; 378(9800): 1396–1407.
    CrossRefPubMed
  346. Baron DM, Franchini M, Goobie SM, et al. Patient blood management during the COVID-19 pandemic: a narrative review. Anaesthesia. 2020; 75(8): 1105–1113.
    CrossRefPubMed
  347. Muñoz M, Gómez-Ramírez S, Campos A, et al. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015; 13(3): 370–379.
    CrossRefPubMed
  348. von Heymann C, Kaufner L, Sander M, et al. Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery? J Thorac Cardiovasc Surg. 2016; 152(5): 1412–1420.
    CrossRefPubMed
  349. Rössler J, Schoenrath F, Seifert B, et al. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. Br J Anaesth. 2020; 124(1): 25–34.
    CrossRefPubMed
  350. Althoff FC, Neb H, Herrmann E, et al. Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg. 2019; 269(5): 794–804.
    CrossRefPubMed
  351. Meybohm P, Herrmann E, Steinbicker AU, et al. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient’s outcome: a prospective, multicenter cohort study with a noninferiority design. Ann Surg. 2016; 264: 203–211.
  352. Frew N, Alexander D, Hood J, et al. Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty. Ann R Coll Surg Engl. 2016; 98(6): 380–386.
    CrossRefPubMed
  353. Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017; 57(6): 1347–1358.
    CrossRefPubMed
  354. So-Osman C, Nelissen RG, Koopman-van Gemert AW, et al. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology. 2014; 120(4): 839–851.
    CrossRefPubMed
  355. Theusinger OM, Kind SL, Seifert B, et al. Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus. 2014; 12(2): 195–203.
    CrossRefPubMed
  356. Froessler B, Palm P, Weber I, et al. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016; 264(1): 41–46.
    CrossRefPubMed
  357. Triphaus C, Judd L, Glaser P, et al. Effectiveness of preoperative iron supplementation in major surgical patients with iron deficiency. Ann Surg. 2019; 274(3): e212–e219.
    CrossRefPubMed
  358. Cappellini MD, Comin-Colet J, Francisco Ade, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017; 92(10): 1068–1078.
    CrossRefPubMed
  359. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus. 2014; 12(3): 296–300.
    CrossRefPubMed
  360. Richards T, Baikady RR, Clevenger B, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020; 396(10259): 1353–1361.
    CrossRefPubMed
  361. Kaufner L, von Heymann C, Henkelmann A, et al. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2020; 8: CD012451.
    CrossRefPubMed
  362. Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017; 72(2): 233–247.
    CrossRefPubMed
  363. World Health Assembly. Availability, safety and quality of blood products. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf (October 27, 2017).
  364. Kotzé A, Harris A, Baker C, et al. British Committee for Standards in Haematology Guidelines on the identification and management of pre-operative anaemia. Br J Haematol. 2015; 171(3): 322–331.
    CrossRefPubMed
  365. Koch CG, Reineks EZ, Tang AS, et al. Contemporary bloodletting in cardiac surgical care. Ann Thorac Surg. 2015; 99(3): 779–784.
    CrossRefPubMed
  366. Riessen R, Behmenburg M, Blumenstock G, et al. A simple "blood-saving bundle" reduces diagnostic blood loss and the transfusion rate in mechanically ventilated patients. PLoS One. 2015; 10(9): e0138879.
    CrossRefPubMed
  367. Shander A, Kaplan LJ, Harris MT, et al. Topical hemostatic therapy in surgery: bridging the knowledge and practice gap. J Am Coll Surg. 2014; 219(3): 570–579.e4.
    CrossRefPubMed
  368. Menkis AH, Martin J, Cheng DCH, et al. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011. Innovations (Phila). 2012; 7(4): 229–241.
    CrossRefPubMed
  369. Anastasiadis K, Murkin J, Antonitsis P, et al. Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS). Interact Cardiovasc Thorac Surg. 2016; 22(5): 647–662.
    CrossRefPubMed
  370. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012; 117(3): 531–547.
    CrossRefPubMed
  371. Weber CF, Zacharowski K, Meybohm P, et al. Hemotherapy algorithms for coagulopathic cardiac surgery patients. Clin Lab. 2014; 60(6): 1059–1063.
    CrossRefPubMed
  372. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S. Pre-operative haematological assessment in patients scheduled for major surgery. Anaesthesia. 2016; 71(Suppl 1): 19–28.
    CrossRefPubMed
  373. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30(6): 270–382.
    CrossRefPubMed
  374. Meybohm P, Zacharowski K, Weber CF. Point-of-care coagulation management in intensive care medicine. Crit Care. 2013; 17(2): 218.
    CrossRefPubMed
  375. Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012; 344: e3054.
    CrossRefPubMed
  376. Devereaux PJ, Marcucci M, Balasubramanian K, et al. Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med. 2022; 386(21): 1986–1997.
    CrossRefPubMed
  377. Meybohm P, Choorapoikayil S, Wessels A, et al. Washed cell salvage in surgical patients: A review and meta-analysis of prospective randomized trials under PRISMA. Medicine (Baltimore). 2016; 95(31): e4490.
    CrossRefPubMed
  378. Santos AA, Silva JP, Silva Ld, et al. Therapeutic options to minimize allogeneic blood transfusions and their adverse effects in cardiac surgery: a systematic review. Rev Bras Cir Cardiovasc. 2014; 29(4): 606–621.
    CrossRefPubMed
  379. Haensig M, Kempfert J, Kempfert PM, et al. Thrombelastometry guided blood-component therapy after cardiac surgery: a randomized study. BMC Anesthesiol. 2019; 19(1): 201.
    CrossRefPubMed
  380. Dias JD, Sauaia A, Achneck HE, et al. Thromboelastography-guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis. J Thromb Haemost. 2019; 17(6): 984–994.
    CrossRefPubMed
  381. Chutipongtanate A, Yasaeng C, Virankabutra T, et al. Systematic comparison of four point-of-care methods versus the reference laboratory measurement of hemoglobin in the surgical ICU setting: a cross-sectional method comparison study. BMC Anesthesiol. 2020; 20(1): 92.
    CrossRefPubMed
  382. Terada R, Ikeda T, Mori Y, et al. Comparison of two point of care whole blood coagulation analysis devices and conventional coagulation tests as a predicting tool of perioperative bleeding in adult cardiac surgery — a pilot prospective observational study in Japan. Transfusion. 2019; 59(11): 3525–3535.
    CrossRefPubMed
  383. Cohen J, Scorer T, Wright Z, et al. A prospective evaluation of thromboelastometry (ROTEM) to identify acute traumatic coagulopathy and predict massive transfusion in military trauma patients in Afghanistan. Transfusion. 2019; 59(S2): 1601–1607.
    CrossRefPubMed
  384. Yates J, Perelman I, Khair S, et al. Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta-analysis. Transfusion. 2019; 59(2): 806–824.
    CrossRefPubMed
  385. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019; 394(10210): 1713–1723.
    CrossRefPubMed
  386. HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet. 2020; 395(10241): 1927–1936.
    CrossRefPubMed
  387. Mukhopadhyay A, Yip HS, Prabhuswamy D, et al. The use of a blood conservation device to reduce red blood cell transfusion requirements: a before and after study. Crit Care. 2010; 14: R7.
  388. Peruzzi WT, Parker MA, Lichtenthal PR, et al. A clinical evaluation of a blood conservation device in medical intensive care unit patients. Crit Care Med. 1993; 21(4): 501–506.
    CrossRefPubMed
  389. Kataife ED, Said S, Braun J, et al. The Haemostasis Traffic Light, a user-centred coagulation management tool for acute bleeding situations: a simulation-based randomised dual-centre trial. Anaesthesia. 2021; 76(7): 902–910.
    CrossRefPubMed
  390. Goodnough LT, Shieh L, Hadhazy E, et al. Improved blood utilization using real-time clinical decision support. Transfusion. 2014; 54(5): 1358–1365.
    CrossRefPubMed
  391. Oliver JC, Griffin RL, Hannon T, et al. The success of our patient blood management program depended on an institution-wide change in transfusion practices. Transfusion. 2014; 54(10 Pt 2): 2617–2624.
    CrossRefPubMed
  392. Kaserer A, Rössler J, Braun J, et al. Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. Anaesthesia. 2019; 74(12): 1534–1541.
    CrossRefPubMed
  393. Sardar M, Azharuddin M, Subedi A, et al. Improving blood transfusion practices in a community hospital setting: our experience with real-time clinical decision support. Med Sci (Basel). 2018; 6(3).
    CrossRefPubMed
  394. Jenkins I, Doucet JJ, Clay B, et al. Transfusing wisely: clinical decision support improves blood transfusion practices. Jt Comm J Qual Patient Saf. 2017; 43(8): 389–395.
    CrossRefPubMed
  395. Staples S, Salisbury RA, King AJ, et al. How do we use electronic clinical decision support and feedback to promote good transfusion practice. Transfusion. 2020; 60(8): 1658–1665.
    CrossRefPubMed
  396. Derzon JH, Clarke N, Alford A, et al. Restrictive transfusion strategy and clinical decision support practices for reducing RBC transfusion overuse. Am J Clin Pathol. 2019; 152(5): 544–557.
    CrossRefPubMed
  397. Dawood MM, Gutpa DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996; 57(1): 37–44.
    CrossRefPubMed
  398. Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. 1997; 96(6): 1882–1887.
    CrossRefPubMed
  399. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004; 351(27): 2795–2804.
    CrossRefPubMed
  400. Wong EYW, Lawrence HP, Wong DT. The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery — a meta-analysis. Can J Anaesth. 2007; 54(9): 705–717.
    CrossRefPubMed
  401. Feng B, Lin J, Jin J, et al. The effect of previous coronary artery revascularization on the adverse cardiac events ninety days after total joint arthroplasty. J Arthroplasty. 2018; 33(1): 235–240.
    CrossRefPubMed
  402. Maron D, Hochman J, Reynolds H, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020; 382(15): 1395–1407.
    CrossRefPubMed
  403. Bainey KR, Alemayehu W, Welsh RC, et al. Long-term clinical outcomes following revascularization in high-risk coronary anatomy patients with stable ischemic heart disease. J Am Heart Assoc. 2021; 10(1): e018104.
    CrossRefPubMed
  404. Windecker S, Neumann FJ, Jüni P, et al. Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 204–212.
    CrossRefPubMed
  405. Räber L, Mintz G, Koskinas K, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2018; 14(6): 656–677.
    CrossRefPubMed
  406. Johnson TW, Räber L, Di Mario C, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2019; 15(5): 434–451.
    CrossRefPubMed
  407. Richardt G, Abdelghani M, Allali A, et al. Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial. Clin Res Cardiol. 2021; 110(2): 162–171.
    CrossRefPubMed
  408. Cassese S, Belle L, Ndrepepa G, et al. Deferred vs immediate stenting in primary percutaneous coronary intervention: a collaborative meta-analysis of randomized trials with cardiac magnetic resonance imaging data. Can J Cardiol. 2018; 34(12): 1573–1580.
    CrossRefPubMed
  409. Belle L, Motreff P, Mangin L, et al. MIMI Investigators*. Comparison of immediate with delayed stenting using the minimalist immediate mechanical intervention approach in acute ST-segment-elevation myocardial infarction: the MIMI study. Circ Cardiovasc Interv. 2016; 9(3): e003388.
    CrossRefPubMed
  410. Hammill BG, Curtis LH, Bennett-Guerrero E, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology. 2008; 108(4): 559–567.
    CrossRefPubMed
  411. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 297(16): 845–850.
    CrossRefPubMed
  412. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
    CrossRefPubMed
  413. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100(10): 1043–1049.
    CrossRefPubMed
  414. Flu WJ, van Kuijk JP, Hoeks SE, et al. Prognostic implications of asymptomatic left ventricular dysfunction in patients undergoing vascular surgery. Anesthesiology. 2010; 112(6): 1316–1324.
    CrossRefPubMed
  415. Cohn SL. Preoperative evaluation for noncardiac surgery. Ann Intern Med. 2016; 165(11): ITC81–ITC96.
    CrossRefPubMed
  416. Smilowitz NR, Banco D, Katz SD, et al. Association between heart failure and perioperative outcomes in patients undergoing non-cardiac surgery. Eur Heart J Qual Care Clin Outcomes. 2021; 7(1): 68–75.
    CrossRefPubMed
  417. Lerman BJ, Popat RA, Assimes TL, et al. Association between heart failure and postoperative mortality among patients undergoing ambulatory noncardiac surgery. JAMA Surg. 2019; 154(10): 907–914.
    CrossRefPubMed
  418. Dhillon A, Khanna A, Randhawa MS, et al. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Heart. 2016; 102(20): 1627–1632.
    CrossRefPubMed
  419. Nagueh SF, Bierig SM, Budoff MJ, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2011; 24(5): 473–498.
    CrossRefPubMed
  420. Kormos RL, Cowger J, Pagani FD, et al. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019; 38(2): 114–126.
    CrossRefPubMed
  421. Roberts SM, Hovord DG, Kodavatiganti R, et al. Ventricular assist devices and non-cardiac surgery. BMC Anesthesiol. 2015; 15: 185.
    CrossRefPubMed
  422. Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014; 63(2): 170–180.
    CrossRefPubMed
  423. Karthikeyan G, Moncur RA, Levine O, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol. 2009; 54(17): 1599–1606.
    CrossRefPubMed
  424. Agarwal S, Rajamanickam A, Bajaj NS, et al. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries. Circ Cardiovasc Qual Outcomes. 2013; 6(2): 193–200.
    CrossRefPubMed
  425. Taniguchi T, Morimoto T, Shiomi H, et al. Elective non-cardiac surgery in patients with severe aortic stenosis — observations from the CURRENT AS registry. Circ J. 2020; 84(7): 1173–1182.
    CrossRefPubMed
  426. Luis SA, Dohaei A, Chandrashekar P, et al. Impact of aortic valve replacement for severe aortic stenosis on perioperative outcomes following major noncardiac surgery. Mayo Clin Proc. 2020; 95(4): 727–737.
    CrossRefPubMed
  427. Okuno T, Yahagi K, Horiuchi Yu, et al. The role of transcatheter aortic valve replacement in the patients with severe aortic stenosis requiring major non-cardiac surgery. Cardiovasc Interv Ther. 2019; 34(4): 345–351.
    CrossRefPubMed
  428. Calleja AM, Dommaraju S, Gaddam R, et al. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol. 2010; 105(8): 1159–1163.
    CrossRefPubMed
  429. Sohrabi B, Kazemi B, Mehryar A, et al. Correlation between pulmonary artery pressure measured by echocardiography and right heart catheterization in patients with rheumatic mitral valve stenosis (a prospective study). Echocardiography. 2016; 33(1): 7–13.
    CrossRefPubMed
  430. Bajaj NS, Agarwal S, Rajamanickam A, et al. Impact of severe mitral regurgitation on postoperative outcomes after noncardiac surgery. Am J Med. 2013; 126(6): 529–535.
    CrossRefPubMed
  431. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018; 379(24): 2307–2318.
    CrossRefPubMed
  432. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015; 36(44): 3075–3128.
    CrossRefPubMed
  433. Polanczyk CA, Goldman L, Marcantonio ER, et al. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med. 1998; 129(4): 279–285.
    CrossRefPubMed
  434. van Diepen S, Bakal JA, McAlister FA, et al. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation. 2011; 124(3): 289–296.
    CrossRefPubMed
  435. Alberte C, Zipes DP. Use of nonantiarrhythmic drugs for prevention of sudden cardiac death. J Cardiovasc Electrophysiol. 2003; 14(Suppl 9): S87–S95.
    CrossRefPubMed
  436. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020; 41(5): 655–720.
    CrossRefPubMed
  437. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999; 99(2): 262–270.
    CrossRefPubMed
  438. Chen SA, Chiang CE, Yang CJ, et al. Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation. 1994; 90(3): 1262–1278.
    CrossRefPubMed
  439. Katritsis DG, Zografos T, Katritsis GD, et al. Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. Europace. 2017; 19(4): 602–606.
    CrossRefPubMed
  440. Pappone C, Vicedomini G, Manguso F, et al. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation. 2014; 130(10): 811–819.
    CrossRefPubMed
  441. Spector P, Reynolds MR, Calkins H, et al. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009; 104(5): 671–677.
    CrossRefPubMed
  442. Potpara TS, Polovina MM, Marinkovic JM, et al. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2013; 168(5): 4744–4749.
    CrossRefPubMed
  443. Mujović N, Dobrev D, Marinković M, et al. The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacol Res. 2020; 151: 104521.
    CrossRefPubMed
  444. Dan GA, Martinez-Rubio A, Agewall S, et al. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace. 2018; 20(5): 731–732an.
    CrossRefPubMed
  445. Ellenbogen KA, Dias VC, Plumb VJ, et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study. J Am Coll Cardiol. 1991; 18(4): 891–897.
    CrossRefPubMed
  446. Phillips BG, Gandhi AJ, Sanoski CA, et al. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy. 1997; 17: 1238–1245.
  447. Platia EV, Michelson EL, Porterfield JK, et al. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 1989; 63(13): 925–929.
    CrossRefPubMed
  448. Sethi NJ, Nielsen EE, Safi S, et al. Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. PLoS One. 2018; 13(3): e0193924.
    CrossRefPubMed
  449. Delle Karth G, Geppert A, Neunteufl T, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med. 2001; 29(6): 1149–1153.
    CrossRefPubMed
  450. Vos MA, Golitsyn SR, Stangl K, et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart. 1998; 79(6): 568–575.
    CrossRefPubMed
  451. Singh S, Zoble RG, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation. 2000; 102(19): 2385–2390.
    CrossRefPubMed
  452. Volgman AS, Carberry PA, Stambler B, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998; 31(6): 1414–1419.
    CrossRefPubMed
  453. Bianconi L, Castro A, Dinelli M, et al. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. Eur Heart J. 2000; 21(15): 1265–1273.
    CrossRefPubMed
  454. Kerola T, Dewland TA, Vittinghoff E, et al. Modifiable predictors of ventricular ectopy in the community. J Am Heart Assoc. 2018; 7(22): e010078.
    CrossRefPubMed
  455. Yang J, Dudum R, Mandyam MC, et al. Characteristics of unselected high-burden premature ventricular contraction patients. Pacing Clin Electrophysiol. 2014; 37(12): 1671–1680.
    CrossRefPubMed
  456. Parreira L, Marinheiro R, Amador P, et al. Frequent premature ventricular contractions. Association of burden and complexity with prognosis according to the presence of structural heart disease. Ann Noninvasive Electrocardiol. 2021; 26(1): e12800.
    CrossRefPubMed
  457. Agarwal V, Vittinghoff E, Whitman IR, et al. Relation between ventricular premature complexes and incident heart failure. Am J Cardiol. 2017; 119(8): 1238–1242.
    CrossRefPubMed
  458. Dukes JW, Dewland TA, Vittinghoff E, et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015; 66(2): 101–109.
    CrossRefPubMed
  459. Marcus GM. Evaluation and management of premature ventricular complexes. Circulation. 2020; 141(17): 1404–1418.
    CrossRefPubMed
  460. Mukharji J, Rude R, Poole W, et al. Risk factors for sudden death after acute myocardial infarction: Two-year follow-up. Am J Cardiol. 1984; 54(1): 31–36.
    CrossRefPubMed
  461. Chen J, Johnson G, Hellkamp AS, et al. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol. 2013; 61(21): 2161–2168.
    CrossRefPubMed
  462. Makimoto H, Zielke S, Clasen L, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res. 2020; 25(1): 5.
    CrossRefPubMed
  463. Sánchez Muñoz JJ, García-Alberola A, Martínez-Sánchez J, et al. Premature ventricular complexes as a trigger for ventricular fibrillation. Revi Esp Cardiol. 2010; 63(7): 798–801.
    CrossRefPubMed
  464. Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol. 2000; 36(5): 1646–1653.
    CrossRefPubMed
  465. Srivathsan K, Gami AS, Ackerman MJ, et al. Treatment of ventricular fibrillation in a patient with prior diagnosis of long QT syndrome: importance of precise electrophysiologic diagnosis to successfully ablate the trigger. Heart Rhythm. 2007; 4(8): 1090–1093.
    CrossRefPubMed
  466. Almendral J, Villacastin JP, Arenal A, et al. Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. Am J Cardiol. 1995; 76(13): 60D–63D.
    CrossRefPubMed
  467. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
    CrossRefPubMed
  468. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006; 295(2): 165–171.
    CrossRefPubMed
  469. Brodine WN, Tung RT, Lee JK, et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol. 2005; 96(5): 691–695.
    CrossRefPubMed
  470. Tilz RR, Lenarczyk R, Scherr D, et al. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey. Europace. 2018; 20(1): 209–213.
    CrossRefPubMed
  471. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace. 2019; 21(8): 1143–1144.
    CrossRefPubMed
  472. Scheuermeyer FX, Grafstein E, Stenstrom R, et al. Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause. Ann Emerg Med. 2012; 60(6): 755–765.e2.
    CrossRefPubMed
  473. Bonfanti L, Annovi A, Sanchis-Gomar F, et al. Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: a real-world 10-year single center experience. Clin Exp Emerg Med. 2019; 6(1): 64–69.
    CrossRefPubMed
  474. Kheiri B, Barbarawi M, Zayed Y, et al. Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol. 2019; 12(11): e007600.
    CrossRefPubMed
  475. Santangeli P, Muser D, Maeda S, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016; 13(7): 1552–1559.
    CrossRefPubMed
  476. Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020; 17(1): e206–e219.
    CrossRefPubMed
  477. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007; 357(26): 2657–2665.
    CrossRefPubMed
  478. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016; 375(2): 111–121.
    CrossRefPubMed
  479. Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010; 375(9708): 31–40.
    CrossRefPubMed
  480. Briceño DF, Gupta T, Romero J, et al. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States. J Cardiovasc Electrophysiol. 2018; 29(5): 771–779.
    CrossRefPubMed
  481. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42(35): 3427–3520.
    CrossRefPubMed
  482. Martí-Almor J, Cladellas M, Bazán V, et al. [Novel predictors of progression of atrioventricular block in patients with chronic bifascicular block]. Rev Esp Cardiol. 2010; 63(4): 400–408.
    PubMed
  483. Santini M, Castro A, Giada F, et al. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study. Circ Arrhythm Electrophysiol. 2013; 6(1): 101–107.
    CrossRefPubMed
  484. Stone ME, Salter B, Fischer A. Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth. 2011; 107(Suppl 1): i16–i26.
    CrossRefPubMed
  485. Cardiac implantable electronic device management (corrected). Anesthesiology. 2020; 132(2): 225–252.
    CrossRefPubMed
  486. Gifford J, Larimer K, Thomas C, et al. ICD-ON registry for perioperative management of CIEDs: most require no change. Pacing Clin Electrophysiol. 2017; 40(2): 128–134.
    CrossRefPubMed
  487. Mahlow WJ, Craft RM, Misulia NL, et al. A perioperative management algorithm for cardiac rhythm management devices: the PACED-OP protocol. Pacing Clin Electrophysiol. 2013; 36(2): 238–248.
    CrossRefPubMed
  488. Neubauer H, Wellmann M, Herzog-Niescery J, et al. Comparison of perioperative strategies in ICD patients: The perioperative ICD management study (PIM study). Pacing Clin Electrophysiol. 2018; 41(11): 1536–1542.
    CrossRefPubMed
  489. Feldman JB, Stone ME. Anesthesia teams managing pacemakers and ICDs for the perioperative period: enhanced patient safety and improved workflows. Curr Opin Anaesthesiol. 2020; 33(3): 441–447.
    CrossRefPubMed
  490. Mickus GJ, Soliman GI, Reed RR, et al. Perioperative management of a leadless pacemaker: the paucity of evidence-based guidelines. J Cardiothorac Vasc Anesth. 2016; 30(6): 1594–1598.
    CrossRefPubMed
  491. Karuppiah S, Prielipp R, Banik RK. Anesthetic consideration for patients with micra leadless pacemaker. Ann Card Anaesth. 2020; 23(4): 493–495.
    CrossRefPubMed
  492. Gifford J, Larimer K, Thomas C, et al. Randomized controlled trial of perioperative ICD management: magnet application versus reprogramming. Pacing Clin Electrophysiol. 2014; 37(9): 1219–1224.
    CrossRefPubMed
  493. Winter J, Kohlmeier A, Shin DI, et al. Subcutaneous implantable cardioverter-defibrillators and sternal wires: a cautionary tale. Circ Arrhythm Electrophysiol. 2014; 7(5): 986–987.
    CrossRefPubMed
  494. Schulman PM, Treggiari MM, Yanez ND, et al. Electromagnetic interference with protocolized electrosurgery dispersive electrode positioning in patients with implantable cardioverter defibrillators. Anesthesiology. 2019; 130(4): 530–540.
    CrossRefPubMed
  495. Baeg MKi, Kim SW, Ko SH, et al. Endoscopic electrosurgery in patients with cardiac implantable electronic devices. Clin Endosc. 2016; 49(2): 176–181.
    CrossRefPubMed
  496. Mangar D, Atlas GM, Kane PB. Electrocautery-induced pacemaker malfunction during surgery. Can J Anaesth. 1991; 38(5): 616–618.
    CrossRefPubMed
  497. Rozner MA. Review of electrical interference in implanted cardiac devices. Pacing Clin Electrophysiol. 2003; 26(4 Pt 1): 923–925.
    CrossRefPubMed
  498. de Cock CC, Spruijt HJ, van Campen LM, et al. Electromagnetic interference of an implantable loop recorder by commonly encountered electronic devices. Pacing Clin Electrophysiol. 2000; 23(10 Pt 1): 1516–1518.
    CrossRefPubMed
  499. Suarez-Fuster L, Oh C, Baranchuk A. Transcutaneous electrical nerve stimulation electromagnetic interference in an implantable loop recorder. J Arrhythm. 2018; 34(1): 96–97.
    CrossRefPubMed
  500. Gilboa SM, Salemi JL, Nembhard WN, et al. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010; 122(22): 2254–2263.
    CrossRefPubMed
  501. Marelli AJ, Ionescu-Ittu R, Mackie AS, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014; 130(9): 749–756.
    CrossRefPubMed
  502. Maxwell BG, Wong JK, Kin C, et al. Perioperative outcomes of major noncardiac surgery in adults with congenital heart disease. Anesthesiology. 2013; 119(4): 762–769.
    CrossRefPubMed
  503. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42(6): 563–645.
    CrossRefPubMed
  504. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39(34): 3165–3241.
    CrossRefPubMed
  505. Ammash NM, Connolly HM, Abel MD, et al. Noncardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol. 1999; 33(1): 222–227.
    CrossRefPubMed
  506. Faraoni D, Zurakowski D, Vo D, et al. Post-operative outcomes in children with and without congenital heart disease undergoing noncardiac surgery. J Am Coll Cardiol. 2016; 67(7): 793–801.
    CrossRefPubMed
  507. Alonso-Gonzalez R, Borgia F, Diller GP, et al. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013; 127(8): 882–890.
    CrossRefPubMed
  508. Maxwell BG, Posner KL, Wong JK, et al. Factors contributing to adverse perioperative events in adults with congenital heart disease: a structured analysis of cases from the closed claims project. Congenit Heart Dis. 2015; 10(1): 21–29.
    CrossRefPubMed
  509. Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017; 136(20): e348–e392.
    CrossRefPubMed
  510. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015; 36(42): 2921–2964.
    CrossRefPubMed
  511. Tuck BC, Townsley MM. Clinical update in pericardial diseases. J Cardiothorac Vasc Anesth. 2019; 33(1): 184–199.
    CrossRefPubMed
  512. Ristić AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014; 35(34): 2279–2284.
    CrossRefPubMed
  513. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005; 127(6): 1952–1959.
    CrossRefPubMed
  514. Canet J, Gallart L, Gomar C, et al. ARISCAT Group. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010; 113(6): 1338–1350.
    CrossRefPubMed
  515. Edrich T, Sadovnikoff N. Anesthesia for patients with severe chronic obstructive pulmonary disease. Curr Opin Anaesthesiol. 2010; 23(1): 18–24.
    CrossRefPubMed
  516. Chau EHL, Lam D, Wong J, et al. Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology. 2012; 117(1): 188–205.
    CrossRefPubMed
  517. Kaw R, Gali B, Collop NA. Perioperative care of patients with obstructive sleep apnea. Curr Treat Options Neurol. 2011; 13(5): 496–507.
    CrossRefPubMed
  518. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37(1): 67–119.
    CrossRefPubMed
  519. Bowker D, Banks D. Pulmonary hypertension in noncardiac surgical patients. In: Kaplan JA, Cronin B, Maus TM. ed. Essentials of Cardiac Anesthesia for Noncardiac Surgery. Elsevier, Philadelphia 2019: 138–164.
  520. Meyer S, McLaughlin VV, Seyfarth HJ, et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J. 2013; 41(6): 1302–1307.
    CrossRefPubMed
  521. Price LC, Montani D, Jaïs X, et al. Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J. 2010; 35(6): 1294–1302.
    CrossRefPubMed
  522. Olsson KM, Halank M, Egenlauf B, et al. Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018; 272S: 46–52.
    CrossRefPubMed
  523. Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia. 2015; 70(1): 56–70.
    CrossRefPubMed
  524. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022.
    CrossRef
  525. Thunberg CA, Gaitan BD, Grewal A, et al. Pulmonary hypertension in patients undergoing cardiac surgery: pathophysiology, perioperative management, and outcomes. J Cardiothorac Vasc Anesth. 2013; 27(3): 551–572.
    CrossRefPubMed
  526. Hayward CS, Kelly RP, Macdonald PS. Inhaled nitric oxide in cardiology practice. Cardiovasc Res. 1999; 43(3): 628–638.
    CrossRefPubMed
  527. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310(9): 959–968.
    CrossRefPubMed
  528. Futier E, Lefrant JY, Guinot PG, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017; 318(14): 1346–1357.
    CrossRefPubMed
  529. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
    CrossRefPubMed
  530. Howell SJ, Sear JW, Foëx P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth. 2004; 92(4): 570–583.
    CrossRefPubMed
  531. Messina A, Robba C, Calabrò L, et al. Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery. Crit Care. 2021; 25(1): 43.
    CrossRefPubMed
  532. Jørgensen ME, Hlatky MA, Køber L, et al. β-blocker-associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery. JAMA Intern Med. 2015; 175(12): 1923–1931.
    CrossRefPubMed
  533. Marino KA, Little MA, Bursac Z, et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? J Clin Anesth. 2003; 15(3): 179–183.
    CrossRefPubMed
  534. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33(13): 1635–1701.
    CrossRefPubMed
  535. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39(9): 763–816.
    CrossRefPubMed
  536. Bonaca MP, Nault P, Giugliano RP, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk). Circulation. 2018; 137(4): 338–350.
    CrossRefPubMed
  537. Anand SS, Bosch J, Eikelboom JW, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018; 391(10117): 219–229.
    CrossRefPubMed
  538. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med. 1993; 118(7): 504–510.
    CrossRefPubMed
  539. Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019; 58(1): S1–S109.e33.
    CrossRefPubMed
  540. Brown LC, Powell JT, Thompson SG, et al. The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy. Health Technol Assess. 2012; 16(9): 1–218.
    CrossRefPubMed
  541. Paravastu SC, Jayarajasingam R, Cottam R, et al. Endovascular repair of abdominal aortic aneurysm. Cochrane Database Syst Rev. 2014(1): CD004178.
    CrossRefPubMed
  542. Stather PW, Sidloff D, Dattani N, et al. Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg. 2013; 100(7): 863–872.
    CrossRefPubMed
  543. Eslami MH, Rybin DV, Doros G, et al. External validation of Vascular Study Group of New England risk predictive model of mortality after elective abdominal aorta aneurysm repair in the Vascular Quality Initiative and comparison against established models. J Vasc Surg. 2018; 67(1): 143–150.
    CrossRefPubMed
  544. Bonaca MP, Bauersachs RM, Hiatt WR, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020; 382(21): 1994–2004.
    CrossRefPubMed
  545. Cutlip DE, Pinto DS. Extracranial carotid disease revascularization. Circulation. 2012; 126(22): 2636–2644.
    CrossRefPubMed
  546. Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011; 80(6): 572–586.
    CrossRefPubMed
  547. Section 3: prevention and treatment of AKI. Kidney Int Suppl (2011). 2012; 2(1): 37–68.
    CrossRefPubMed
  548. Romagnoli S, Ricci Z, Ronco C. Perioperative acute kidney injury: prevention, early recognition, and supportive measures. Nephron. 2018; 140(2): 105–110.
    CrossRefPubMed
  549. Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009; 110(3): 505–515.
    CrossRefPubMed
  550. Rebholz CM, Inker LA, Chen Y, et al. Risk of ESRD and mortality associated with change in filtration markers. Am J Kidney Dis. 2017; 70(4): 551–560.
    CrossRefPubMed
  551. McCullough PA, Choi JP, Feghali GA, et al. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2016; 68(13): 1465–1473.
    CrossRefPubMed
  552. Section 2: AKI definition. Kidney Int Suppl. 2012; 2(1): 19–36.
    CrossRefPubMed
  553. Goren O, Matot I, et al. Perioperative acute kidney injury. Br J Anaesth. 2015; 115(Suppl 2): ii3–ii14.
    CrossRefPubMed
  554. Zealley I, Wang H, Donnan PT, et al. Exposure to contrast media in the perioperative period confers no additional risk of acute kidney injury in surgical patients. Nephrol Dial Transplant. 2018; 33(10): 1751–1756.
    CrossRefPubMed
  555. STARSurg Collaborative. Perioperative intravenous contrast administration and the incidence of acute kidney injury after major gastrointestinal surgery: prospective, multicentre cohort study. Br J Surg. 2020; 107: 1023–1032.
    CrossRefPubMed
  556. Meersch M, Schmidt C, Zarbock A. Patient with chronic renal failure undergoing surgery. Curr Opin Anaesthesiol. 2016; 29(3): 413–420.
    CrossRefPubMed
  557. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017; 390(10113): 2627–2642.
    CrossRefPubMed
  558. Lavie CJ, Arena R, Alpert MA, et al. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018; 15(1): 45–56.
    CrossRefPubMed
  559. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016; 118(11): 1752–1770.
    CrossRefPubMed
  560. De Hert S, Staender S, Fritsch G, et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2018; 35(6): 407–465.
    CrossRefPubMed
  561. Lavie CJ, De Schutter A, Parto P, et al. Obesity and prevalence of cardiovascular diseases and prognosis — the obesity paradox updated. Prog Cardiovasc Dis. 2016; 58(5): 537–547.
    CrossRefPubMed
  562. Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018; 61(2): 142–150.
    CrossRefPubMed
  563. Valentijn TM, Galal W, Tjeertes EKM, et al. The obesity paradox in the surgical population. Surgeon. 2013; 11(3): 169–176.
    CrossRefPubMed
  564. Hidvegi R, Puelacher C, Gualandro DM, et al. BASEL-P.M.I. Investigators. Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery. Clin Res Cardiol. 2020; 109(9): 1140–1147.
    CrossRefPubMed
  565. Ross R, Blair S, Arena R, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation. 2016; 134(24): e653–e699.
    CrossRefPubMed
  566. McAuley PA, Artero EG, Sui X, et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc. 2012; 87(5): 443–451.
    CrossRefPubMed
  567. Pedersen BK. Body mass index-independent effect of fitness and physical activity for all-cause mortality. Scand J Med Sci Sports. 2007; 17(3): 196–204.
    CrossRefPubMed
  568. Roman M, Monaghan A, Serraino GF, et al. Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes. Br J Surg. 2019; 106(3): 181–189.
    CrossRefPubMed
  569. McCullough PA, Gallagher MJ, Dejong AT, et al. Cardiorespiratory fitness and short-term complications after bariatric surgery. Chest. 2006; 130(2): 517–525.
    CrossRefPubMed
  570. Smith TB, Stonell C, Purkayastha S, et al. Cardiopulmonary exercise testing as a risk assessment method in non cardio-pulmonary surgery: a systematic review. Anaesthesia. 2009; 64(8): 883–893.
    CrossRefPubMed
  571. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733): 2215–2222.
    CrossRefPubMed
  572. Kadoi Y. Anesthetic considerations in diabetic patients. Part II: intraoperative and postoperative management of patients with diabetes mellitus. J Anesth. 2010; 24(5): 748–756.
    CrossRefPubMed
  573. Grant PJ, Cosentino F, Cosentino F, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020; 41(2): 255–323.
    CrossRefPubMed
  574. American Diabetes Association. 15. Diabetes care in the hospital: standards of medical care in diabetes 2020. Diabetes Care. 2021; 44(Suppl 1): S211–S220.
    CrossRefPubMed
  575. Shah NJ, Leis A, Kheterpal S, et al. Association of intraoperative hyperglycemia and postoperative outcomes in patients undergoing non-cardiac surgery: a multicenter retrospective study. BMC Anesthesiol. 2020; 20(1): 106.
    CrossRefPubMed
  576. Aharaz A, Pottegård A, Henriksen DP, et al. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study. PLoS One. 2018; 13(5): e0196122.
    CrossRefPubMed
  577. Vogt AP, Bally L. Perioperative glucose management: Current status and future directions. Best Pract Res Clin Anaesthesiol. 2020; 34(2): 213–224.
    CrossRefPubMed
  578. Pasquel FJ, Gomez-Huelgas R, Anzola I, et al. Predictive value of admission hemoglobin a1c on inpatient glycemic control and response to insulin therapy in medicine and surgery patients with type 2 diabetes. Diabetes Care. 2015; 38(12): e202–e203.
    CrossRefPubMed
  579. Carpenter DL, Gregg SR, Xu K, et al. Prevalence and impact of unknown diabetes in the ICU. Crit Care Med. 2015; 43(12): e541–e550.
    CrossRefPubMed
  580. van den Boom W, Schroeder RA, Manning MW, et al. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018; 41(4): 782–788.
    CrossRefPubMed
  581. Dhatariya K, Levy N, Kilvert A, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012; 29(4): 420–433.
    CrossRefPubMed
  582. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002; 346(13): 975–980.
    CrossRefPubMed
  583. Kirschner M, do Ó Hartmann N, Parmentier S, et al. Primary thromboprophylaxis in patients with malignancies: daily practice recommendations by the hemostasis working party of the german society of hematology and medical oncology (DGHO), the society of thrombosis and hemostasis research (GTH), and the austrian society of hematology and oncology (ÖGHO). Cancers (Basel). 2021; 13(12): 2905.
    CrossRefPubMed
  584. Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022.
    CrossRefPubMed
  585. COVIDSurg Collaborative, GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021; 76(6): 748–758.
    CrossRefPubMed
  586. COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 2022; 77(1): 28–39.
    CrossRefPubMed
  587. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020; 116(10): 1666–1687.
    CrossRefPubMed
  588. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265–1273.
    CrossRefPubMed
  589. Rohatgi N, Smilowitz NR, Reejhsinghani R. Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of COVID-19. JAMA Surg. 2022; 157(3): 187–188.
    CrossRefPubMed
  590. Deng JZ, Chan JS, Potter AL, et al. The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the united states. Ann Surg. 2022; 275(2): 242–246.
    CrossRefPubMed
  591. Anesthesia Patient Safety Foundation. American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Joint Statement on Elective Surgery and Anesthesia for Patients after COVID-19 Infection. https://www.apsf.org/newsupdates/asa-and-apsf-joint-statement-on-elective-surgery-and-anesthesia-forpatients-after-covid-19-infection/ (March 30, 2022).
  592. Mellin-Olsen J, Staender S, Whitaker DK, et al. The Helsinki Declaration on patient safety in anaesthesiology. Eur J Anaesthesiol. 2010; 27(7): 592–597.
    CrossRefPubMed
  593. De Hert S. Perioperative monitoring: anaesthesiology. In: Camm AJ, Lüscher TF, Maurer G, Serruys PW. ed. ESC CardioMed. 3rd ed. Oxford University Press, Oxford 2018: 2683–2686.
  594. Hamilton-Davies C, Mythen MG, Salmon JB, et al. Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med. 1997; 23(3): 276–281.
    CrossRefPubMed
  595. Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013; 41(7): 1774–1781.
    CrossRefPubMed
  596. Gaba DM. Improving anesthesiologists' performance by simulating reality. Anesthesiology. 1992; 76(4): 491–494.
    PubMed
  597. Runciman WB. Commentary on equipment recommendations. Eur J Anaesthesiol Suppl. 1993; 7: 16–18.
    PubMed
  598. Block FE, Nuutinen L, Ballast B. Optimization of alarms: a study on alarm limits, alarm sounds, and false alarms, intended to reduce annoyance. J Clin Monit Comput. 1999; 15: 75–83.
  599. De Hert S, Moerman A. Anesthetic preconditioning: have we found the holy grail of perioperative cardioprotection? J Cardiothorac Vasc Anesth. 2018; 32(3): 1135–1136.
    CrossRefPubMed
  600. Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007; 107(2): 213–220.
    CrossRefPubMed
  601. Vernooij LM, van Klei WA, Machina M, et al. Different methods of modelling intraoperative hypotension and their association with postoperative complications in patients undergoing non-cardiac surgery. Br J Anaesth. 2018; 120(5): 1080–1089.
    CrossRefPubMed
  602. Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019; 122(5): 563–574.
    CrossRefPubMed
  603. Sessler DI, Meyhoff CS, Zimmerman NM, et al. Period-dependent associations between hypotension during and for four days after noncardiac surgery and a composite of myocardial infarction and death: a substudy of the POISE-2 trial. Anesthesiology. 2018; 128(2): 317–327.
    CrossRefPubMed
  604. Ladha KS, Beattie WS, Tait G, et al. Association between preoperative ambulatory heart rate and postoperative myocardial injury: a retrospective cohort study. Br J Anaesth. 2018; 121(4): 722–729.
    CrossRefPubMed
  605. Abbott TEF, Ackland GL, Archbold RA, et al. Preoperative heart rate and myocardial injury after non-cardiac surgery: results of a predefined secondary analysis of the VISION study. Br J Anaesth. 2016; 117(2): 172–181.
    CrossRefPubMed
  606. Abbott TEF, Minto G, Lee AM, et al. Elevated preoperative heart rate is associated with cardiopulmonary and autonomic impairment in high-risk surgical patients. Br J Anaesth. 2017; 119(1): 87–94.
    CrossRefPubMed
  607. Ruetzler K, Yilmaz HO, Turan A, et al. Intra-operative tachycardia is not associated with a composite of myocardial injury and mortality after noncardiac surgery: A retrospective cohort analysis. Eur J Anaesthesiol. 2019; 36(2): 105–113.
    CrossRefPubMed
  608. Straarup TS, Hausenloy DJ, Rolighed Larsen JK. Cardiac troponins and volatile anaesthetics in coronary artery bypass graft surgery: A systematic review, meta-analysis and trial sequential analysis. Eur J Anaesthesiol. 2016; 33(6): 396–407.
    CrossRefPubMed
  609. Landoni G, Lomivorotov VV, Nigro Neto C, et al. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N Engl J Med. 2019; 380(13): 1214–1225.
    CrossRefPubMed
  610. Lurati Buse GAL, Schumacher P, Seeberger E, et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation. 2012; 126(23): 2696–2704.
    CrossRefPubMed
  611. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000; 321(7275): 1493.
    CrossRefPubMed
  612. Bos EME, Hollmann M, Lirk P. Safety and efficacy of epidural analgesia. Curr Opin Anaesthesiol. 2017; 30(6): 736–742.
    CrossRefPubMed
  613. Gogarten W, Vandermeulen E, Van Aken H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010; 27(12): 999–1015.
    CrossRefPubMed
  614. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011; 112(6): 1392–1402.
    CrossRefPubMed
  615. Grocott MPW, Dushianthan A, Hamilton MA, et al. Optimisation Systematic Review Steering Group. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. Cochrane Database Syst Rev. 2012; 11: CD004082.
    CrossRefPubMed
  616. Cecconi M, Corredor C, Arulkumaran N, et al. Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups. Crit Care. 2013; 17(2): 209.
    CrossRefPubMed
  617. Arulkumaran N, Corredor C, Hamilton MA, et al. Cardiac complications associated with goal-directed therapy in high-risk surgical patients: a meta-analysis. Br J Anaesth. 2014; 112(4): 648–659.
    CrossRefPubMed
  618. Nicklas JY, Diener O, Leistenschneider M, et al. Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth. 2020; 125(2): 122–132.
    CrossRefPubMed
  619. Taenzer AH, Pyke JB, McGrath SP. A review of current and emerging approaches to address failure-to-rescue. Anesthesiology. 2011; 115(2): 421–431.
    CrossRefPubMed
  620. Pyke J, Taenzer AH, Renaud CE, et al. Developing a continuous monitoring infrastructure for detection of inpatient deterioration. Jt Comm J Qual Patient Saf. 2012; 38(9): 428–431.
    CrossRefPubMed
  621. McGrath SP, Taenzer AH, Karon N, et al. Surveillance monitoring management for general care units: strategy, design, and implementation. Jt Comm J Qual Patient Saf. 2016; 42(7): 293–302.
    CrossRefPubMed
  622. Taenzer AH, Spence BC. The afferent limb of rapid response systems: continuous monitoring on general care units. Crit Care Clin. 2018; 34(2): 189–198.
    CrossRefPubMed
  623. Liu SS, Wu CL. The effect of analgesic technique on postoperative patient-reported outcomes including analgesia: a systematic review. Anesth Analg. 2007; 105(3): 789–808.
    CrossRefPubMed
  624. White PF, Kehlet H. Postoperative pain management and patient outcome: time to return to work! Anesth Analg. 2007; 104(3): 487–489.
    CrossRefPubMed
  625. Turan A, Leung S, Bajracharya GR, et al. Acute postoperative pain is associated with myocardial injury after noncardiac surgery. Anesth Analg. 2020; 131(3): 822–829.
    CrossRefPubMed
  626. Olsen AM, Fosbøl E, Lindhardsen J, et al. Long-Term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction. Circulation. 2012; 126(16): 1955–1963.
    CrossRef
  627. Schmidt M, Sørensen HT, Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 2018; 362: k3426.
    CrossRefPubMed
  628. Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol. 2009; 103(9): 1227–1237.
    CrossRefPubMed
  629. Ray WA, Varas-Lorenzo C, Chung CP, et al. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes. 2009; 2(3): 155–163.
    CrossRefPubMed
  630. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007; 115: 1634–1642.
    CrossRefPubMed
  631. Schug SA, Joshi GP, Camu F, et al. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data. Anesth Analg. 2009; 108(1): 299–307.
    CrossRefPubMed
  632. Liu SS, Bae JJ, Bieltz M, et al. Association of perioperative use of nonsteroidal anti-inflammatory drugs with postoperative myocardial infarction after total joint replacement. Reg Anesth Pain Med. 2012; 37(1): 45–50.
    CrossRefPubMed
  633. Schmidt M, Lamberts M, Olsen AMS, et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J. 2016; 37(13): 1015–1023.
    CrossRefPubMed
  634. Khanna AK, Shaw AD, Stapelfeldt WH, et al. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesth Analg. 2021; 132(6): 1654–1665.
    CrossRefPubMed
  635. Aldington S, Shirtcliffe P, Weatherall M, et al. Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. N Z Med J. 2005; 118(1226): U1755.
    PubMed
  636. Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015; 373(23): 2258–2269.
    CrossRefPubMed
  637. Sabate S, Mases A, Guilera N, et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in noncardiac surgery. Br J Anaesth. 2011; 107(6): 879–890.
    CrossRefPubMed
  638. Smilowitz NR, Redel-Traub G, Hausvater A, et al. Myocardial injury after noncardiac surgery: a systematic review and meta-analysis. Cardiol Rev. 2019; 27(6): 267–273.
    CrossRefPubMed
  639. Smilowitz NR, Gupta N, Guo Yu, et al. Perioperative acute myocardial infarction associated with non-cardiac surgery. Eur Heart J. 2017; 38(31): 2409–2417.
    CrossRefPubMed
  640. Master AM, Dack S, Jaffe HL. Postoperative coronary artery occlusion. JAMA. ; 1938: 1415–1418.
  641. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011; 154(8): 523–528.
    CrossRefPubMed
  642. Borges FK, Devereaux PJ. Physicians should obtain perioperative cardiac troponin measurements in at-risk patients undergoing noncardiac surgery. Clin Chem. 2021; 67(1): 50–53.
    CrossRefPubMed
  643. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018; 138: e618–e651.
    CrossRefPubMed
  644. Toda H, Nakamura K, Shimizu K, et al. Effects of bisoprolol transdermal patches for prevention of perioperative myocardial injury in high-risk patients undergoing non-cardiac surgery — multicenter randomized controlled study. Circ J. 2020; 84(4): 642–649.
    CrossRefPubMed
  645. Devereaux PJ, Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. Eur Heart J. 2020; 41(32): 3083–3091.
    CrossRefPubMed
  646. Ruetzler K, Smilowitz NR, Berger JS, et al. Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American Heart Association. Circulation. 2021; 144(19): e287–e305.
    CrossRefPubMed
  647. Borges FK, Sheth T, Patel A, et al. Accuracy of physicians in differentiating type 1 and type 2 myocardial infarction based on clinical information. CJC Open. 2020; 2(6): 577–584.
    CrossRefPubMed
  648. Gualandro DM, Puelacher C, Lurati Buse G, et al. Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I. Clin Res Cardiol. 2021; 110(9): 1450–1463.
    CrossRefPubMed
  649. Park J, Oh AhR, Kwon JH, et al. Association between cardiologist evaluation and mortality in myocardial injury after non-cardiac surgery. Heart. 2022; 108(9): 695–702.
    CrossRefPubMed
  650. Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018; 391(10137): 2325–2334.
    CrossRefPubMed
  651. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
    CrossRefPubMed
  652. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respir J. 2019; 54(3): 543–603.
    CrossRefPubMed
  653. Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015; 36(10): 605–614.
    CrossRefPubMed
  654. Neely RC, Byrne JG, Gosev I, et al. Surgical embolectomy for acute massive and submassive pulmonary embolism in a series of 115 patients. Ann Thorac Surg. 2015; 100(4): 1245–1251.
    CrossRefPubMed
  655. Conen D, Alonso-Coello P, Douketis J, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. Eur Heart J. 2020; 41(5): 645–651.
    CrossRefPubMed
  656. AlTurki A, Marafi M, Proietti R, et al. Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2020; 13(1): e007437.
    CrossRefPubMed
  657. Chebbout R, Heywood EG, Drake TM, et al. A systematic review of the incidence of and risk factors for postoperative atrial fibrillation following general surgery. Anaesthesia. 2018; 73(4): 490–498.
    CrossRefPubMed
  658. Albini A, Malavasi VL, Vitolo M, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. Eur J Intern Med. 2021; 85: 27–33.
    CrossRefPubMed
  659. Hyun J, Cho MS, Nam GB, et al. Natural course of new-onset postoperative atrial fibrillation after noncardiac surgery. J Am Heart Assoc. 2021; 10(7): e018548.
    CrossRefPubMed
  660. Heywood EG, Drake TM, Bradburn M, et al. Atrial fibrillation after gastrointestinal surgery: incidence and associated risk factors. J Surg Res. 2019; 238: 23–28.
    CrossRefPubMed
  661. Lin MH, Kamel H, Singer DE, et al. Perioperative/Postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke. 2019; 50(6): 1364–1371.
    CrossRefPubMed
  662. Dobrev D, Aguilar M, Heijman J, et al. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019; 16(7): 417–436.
    CrossRefPubMed
  663. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291(14): 1720–1729.
    CrossRefPubMed
  664. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004; 43(5): 742–748.
    CrossRefPubMed
  665. Cardinale D, Sandri MT, Colombo A, et al. Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE trial. Ann Surg. 2016; 264(2): 244–251.
    CrossRefPubMed
  666. Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013; 2013(1): CD003611.
    CrossRefPubMed
  667. Ozaydin M, Icli A, Yucel H, et al. Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J. 2013; 34(8): 597–604.
    CrossRefPubMed
  668. O'Neal JB, Billings FT, Liu X, et al. Effect of preoperative beta-blocker use on outcomes following cardiac surgery. Am J Cardiol. 2017; 120(8): 1293–1297.
    CrossRef
  669. Buckley MS, Nolan PE, Slack MK, et al. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy. 2007; 27(3): 360–368.
    CrossRefPubMed
  670. Riber LP, Christensen TD, Jensen HK, et al. Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. Ann Thorac Surg. 2012; 94(2): 339–346.
    CrossRefPubMed
  671. Tisdale JE, Wroblewski HA, Wall DS, et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg. 2009; 88(3): 886–895.
    CrossRefPubMed
  672. Yuan X, Du J, Liu Qi, et al. Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials. Int J Cardiol. 2017; 228: 958–966.
    CrossRefPubMed
  673. Zheng Z, Jayaram R, Jiang L, et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016; 374(18): 1744–1753.
    CrossRefPubMed
  674. Fairley JL, Zhang L, Glassford NJ, et al. Magnesium status and magnesium therapy in cardiac surgery: A systematic review and meta-analysis focusing on arrhythmia prevention. J Crit Care. 2017; 42: 69–77.
    CrossRefPubMed
  675. Tabbalat RA, Hamad NM, Alhaddad IA, et al. Effect of colchiciNe on the inciDence of atrial fibrillation in open heart surgery patients: END-AF trial. Am Heart J. 2016; 178: 102–107.
    CrossRefPubMed
  676. Wang W, Mei Y, Yuan X, et al. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation. J Thorac Cardiovasc Surg. 2016; 151(1): 80–85.
    CrossRef
  677. Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012; 308(17): 1761–1767.
    CrossRefPubMed
  678. Whitlock RP, Devereaux PJ, Teoh KH, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015; 386(10000): 1243–1253.
    CrossRefPubMed
  679. Kowey PR, Dorian P, Mitchell LB, et al. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009; 2(6): 652–659.
    CrossRefPubMed
  680. Gillinov AM, Bagiella E, Moskowitz AJ, et al. CTSN. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016; 374(20): 1911–1921.
    CrossRefPubMed
  681. Saxena A, Dinh DT, Smith JA, et al. Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol. 2012; 109(2): 219–225.
    CrossRefPubMed
  682. Gialdini G, Nearing K, Bhave PD, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA. 2014; 312(6): 616–622.
    CrossRefPubMed
  683. Horwich P, Buth KJ, Légaré JF. New onset postoperative atrial fibrillation is associated with a long-term risk for stroke and death following cardiac surgery. J Card Surg. 2013; 28(1): 8–13.
    CrossRefPubMed
  684. Ahlsson A, Fengsrud E, Bodin L, et al. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg. 2010; 37(6): 1353–1359.
    CrossRefPubMed
  685. Butt JH, Xian Y, Peterson ED, et al. Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation. JAMA Cardiol. 2018; 3(5): 417–424.
    CrossRefPubMed
  686. Butt JH, Olesen JB, Havers-Borgersen E, et al. Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery. J Am Coll Cardiol. 2018; 72(17): 2027–2036.
    CrossRefPubMed
  687. Selim M. Perioperative stroke. N Engl J Med. 2007; 356(7): 706–713.
    CrossRefPubMed
  688. Macellari F, Paciaroni M, Agnelli G, et al. Perioperative stroke risk in nonvascular surgery. Cerebrovasc Dis. 2012; 34(3): 175–181.
    CrossRefPubMed
  689. Mashour GA, Shanks AM, Kheterpal S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology. 2011; 114: 1289–1296.
    CrossRefPubMed
  690. Ng JLW, Chan MTV, Gelb AW. Perioperative stroke in noncardiac, nonneurosurgical surgery. Anesthesiology. 2011; 115(4): 879–890.
    CrossRefPubMed
  691. Walicka M, Tuszyńska A, Chlebus M, et al. Predictors of in-hospital mortality in surgical wards: a multivariable retrospective cohort analysis of 2,800,069 hospitalizations. World J Surg. 2021; 45(2): 480–487.
    CrossRefPubMed
  692. Mattingly AS, Lerman BJ, Popat R, et al. Association of sex with postoperative mortality among patients with heart failure who underwent elective noncardiac operations. JAMA Netw Open. 2019; 2(11): e1914420.
    CrossRefPubMed
  693. World Health Organization. Prevalence of anaemia in women of reproductive age (aged 15–49) (%). In: Global Health Observatory. Geneva: World Health Organization; 2022. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalenceof-anaemia-in-women-of-reproductive-age-(-).
  694. Gombotz H, Schreier G, Neubauer S, et al. Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study. BMJ Open. 2016; 6(12): e012210.
    CrossRefPubMed
  695. Riesenhuber M, Spannbauer A, Rauscha F, et al. Sex differences and long-term outcome in patients with pacemakers. Front Cardiovasc Med. 2020; 7: 569060.
    CrossRefPubMed
  696. Varma N, Mittal S, Prillinger JB, et al. Survival in women versus men following implantation of pacemakers, defibrillators, and cardiac resynchronization therapy devices in a large, nationwide cohort. J Am Heart Assoc. 2017; 6(5).
    CrossRefPubMed
  697. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005; 112(12): 1687–1691.
    CrossRefPubMed
  698. Aktaa S, Batra G, Wallentin L, et al. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes. 2022; 8(1): 4–13.
    CrossRefPubMed
  699. Minchin M, Roland M, Richardson J, et al. Quality of care in the United Kingdom after removal of financial incentives. N Engl J Med. 2018; 379(10): 948–957.
    CrossRefPubMed
  700. Song Z, Ji Y, Safran DG, et al. Health care spending, utilization, and quality 8 years into global payment. N Engl J Med. 2019; 381(3): 252–263.
    CrossRefPubMed
  701. Arbelo E, Aktaa S, Bollmann A, et al. Quality indicators for the care and outcomes of adults with atrial fibrillation. Europace. 2021; 23(4): 494–495.
    CrossRefPubMed
  702. Schiele F, Aktaa S, Rossello X, et al. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group. Eur Heart J Acute Cardiovasc Care. 2021; 10(2): 224–233.
    CrossRefPubMed
  703. Aktaa S, Abdin A, Arbelo E, et al. European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology. Europace. 2022; 24(1): 165–172.
    CrossRefPubMed
  704. Corrigendum to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021; 42(23): 2298.
    CrossRefPubMed
  705. Batra G, Aktaa S, Wallentin L, et al. Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart). Eur Heart J Qual Care Clin Outcomes. 2021 [Epub ahead of print].
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note